Alzheimer disease, including avohilmo

G6_ALZHEIMER_INCLAVO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G30 1 out of 7 registries used, show all original rules.	14242
4. Check minimum number of events None	14242
5. Include endpoints G6_ALZHEIMER	24772
6. Filter based on genotype QC (FinnGen only)	21755

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	G6_ALZHEIMER_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_ALZHEIMER
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G30
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer disease, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21755	10713	11042
Unadjusted period prevalence (%)	4.44	3.80	5.06
Median age at first event (years)	80.52	80.58	80.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19600: Matched controls
135618

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

321.8

6057

25830

TAB00

NOMESCO Finland

Lumbar puncture

4.1

318.2

1012

1759

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

122.2

317.8

227

N06AX26

ATC

vortioxetine; oral

3.4

310.3

1305

2775

WYA20

NOMESCO Finland

Home visit

6.4

307.7

1038

1171

SPAT1234

SPAT

Support of social functional capacity

3.2

307.7

2064

4880

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

64.5

307.7

4885

694

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

307.7

2591

7050

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.1

307.7

2181

3981

AXX01, ,

SPAT

3.7

307.7

1876

3725

N05AH04

ATC

quetiapine; oral

3.6

307.7

4219

9597

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

33.3

307.7

3092

759

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

+∞

307.7

5675

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

307.7

3593

9005

P20

ICPC

Memory disturbance

9.7

307.7

10931

15598

N06DA02

ATC

donepezil; oral

59.2

307.7

9324

2047

SPAT1216

SPAT

Assessment of functional ability

2.4

307.7

5358

18294

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

307.7

4617

17512

N06DA03

ATC

rivastigmine; oral, transdermal

31.8

307.7

5885

1804

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

204.2

307.7

793

F06.7

ICD-10 Finland

Mild cognitive disorder

4.8

307.7

1753

2708

SPAT1053

SPAT

Memory test

4.0

307.7

7601

18724

F05.1

ICD-10 Finland

Delirium superimposed on dementia

13.3

307.7

603

323

SPAT1254

SPAT

Administration of medicine

2.1

307.7

4227

15524

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

307.7

1373

2805

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

81.6

307.7

5218

600

N06DX01

ATC

memantine; oral

88.3

307.7

12049

2406

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

71.3

307.7

830

G30.0

ICD-10 Finland

Alzheimer disease with early onset

+∞

307.7

1265

G30

ICD-10 Finland

Alzheimer disease

+∞

307.7

1618

F0019, G301,

ICD-10 Finland

4895.2

307.7

690

N05AX08

ATC

risperidone; systemic

9.6

307.7

5465

5273

R41.3

ICD-10 Finland

Other amnesia

5.3

307.7

1567

2197

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

307.7

4629

17626

G30.8

ICD-10 Finland

Other Alzheimer disease

+∞

307.7

3722

P70

ICPC

Dementia

22.3

307.7

2637

939

N06DA04

ATC

galantamine; oral

26.0

307.7

2815

868

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

307.7

8166

36963

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

91.4

307.7

1388

113

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

6277

24669

F009, G309,

ICD-10 Finland

1424.8

307.7

417

N05BA04

ATC

oxazepam; oral

2.1

307.7

5991

23501

G30.1

ICD-10 Finland

Alzheimer disease with late onset

+∞

307.7

11956

F03

ICD-10 Finland

Unspecified dementia

6.4

307.7

3371

4276

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.7

307.7

6262

8822

A28

ICPC

Limited function/disability NOS

2.9

307.7

7688

24380

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

64.2

307.7

577

AA1AD

NOMESCO Finland

CT of head and brain

1.8

303.7

7636

35517

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.2

303.0

734

1008

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

94.9

297.7

217

N03AG01

ATC

valproic acid; systemic, rectal

3.2

268.8

1241

2797

N06AX11

ATC

mirtazapine; oral

1.8

265.6

6658

30628

A04

ICPC

Weakness/tiredness general

2.0

265.1

3937

15333

L28

ICPC

Limited function/disability (L)

1.8

263.7

5497

23921

N05AH03

ATC

olanzapine; systemic

3.2

227.4

1046

2347

F00

ICD-10 Finland

Dementia in Alzheimer disease

17.8

227.1

236

OAB76

NOMESCO Finland

General guidance on nutrition and food

14.6

222.2

251

120

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

110.9

220.9

159

N02AA05

ATC

oxycodone; systemic

1.7

208.6

5036

22600

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

8.8

207.7

316

253

AXX01

NOMESCO Finland

Memory assessment

6.9

203.5

375

385

SPAT1304

SPAT

Counselling and guidance related to ageing

2.0

200.9

2587

9486

F0009, G300,

ICD-10 Finland

+∞

198.2

220

SPAT1101

SPAT

Orthostatic test

2.5

197.7

1506

4439

U04

ICPC

Incontinence urine

2.2

195.7

1851

6009

N05AD01

ATC

haloperidol; systemic

3.0

194.1

990

2361

SPAT1301

SPAT

No procedures

1.6

189.2

6841

33925

N06AB10

ATC

escitalopram; oral

1.9

181.7

2698

10375

A29

ICPC

General symptom/complaint other

1.8

181.2

3226

13158

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

180.5

1511

4645

OAB48

NOMESCO Finland

Lifestyle advice and guidance

11.3

180.5

233

144

N02BE01

ATC

paracetamol; systemic, rectal

1.8

180.0

16861

104376

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

47.5

179.8

143

XA800

NOMESCO Finland

Neuropsychological investigation

3.4

178.4

722

1488

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.0

177.1

583

1036

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

174.8

1510

4705

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

172.5

2462

9328

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

168.7

6925

35133

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.7

160.0

1021

2750

F0014, G301,

ICD-10 Finland

322.0

159.1

185

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.0

156.3

518

925

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

153.6

1393

4425

SPAT1252

SPAT

Overall medication plan or its review

2.0

152.7

1865

6668

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

152.4

1372

4344

A06AD11

ATC

lactulose; oral

1.6

152.0

4166

19086

S01.0

ICD-10 Finland

Open wound of scalp

2.0

151.7

1956

7131

Z75.5

ICD-10 Finland

Holiday relief care

4.7

150.1

398

592

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

5.3

147.9

344

453

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

146.6

3535

15642

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

146.4

2882

12046

N27

ICPC

Fear of neurological disease other

3.4

144.8

582

1193

130

Kela drug reimbursment

Malignant tumour

0.3

143.8

508

10258

F0029, G308,

ICD-10 Finland

1144.4

141.9

160

R55

ICD-10 Finland

Syncope and collapse

1.7

140.3

2926

12420

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

57.8

139.9

108

R1250

NOMESCO Finland

Evaluation of functional capability

3.3

136.8

602

1309

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

132.0

766

1959

AA1AD, ,

SPAT

5.2

131.2

314

425

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

131.0

1264

4114

F001, G301,

ICD-10 Finland

122.4

128.4

158

SPAT1360

SPAT

Extensive global examination

2.0

127.8

1658

6041

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

120.8

1575

5744

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

4.1

120.7

381

655

F21, ,

ICPC

4.5

120.6

340

533

S06.0

ICD-10 Finland

Concussion

1.8

114.1

2059

8341

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

112.3

2127

8739

H02AB02

ATC

dexamethasone; systemic

0.4

111.2

630

10331

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

37.6

110.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

109.7

4128

38926

SPAT1229

SPAT

Assessment of need for aid

1.8

109.6

2014

8198

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

108.8

1804

20582

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

107.0

3653

17442

Z29

ICPC

Social problem NOS

3.2

102.6

468

1040

R42

ICD-10 Finland

Dizziness and giddiness

1.4

98.6

5197

27061

SPAT1139

SPAT

Nutrition survey

2.3

98.1

811

2465

IHZ08, ,

SPAT

6.1

92.4

188

216

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

91.2

756

2299

ICB01, ,

SPAT

6.0

91.1

187

217

W19

ICD-10 Finland

Unspecified fall

1.7

91.0

2071

8924

N06AB06

ATC

sertraline; oral

1.8

89.2

1411

5470

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

87.1

2265

10095

S70.0

ICD-10 Finland

Contusion of hip

2.1

86.9

990

3427

C10AA01

ATC

simvastatin; oral

1.3

84.3

10163

60236

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

12.4

83.5

102

SPAT1172

SPAT

Guidance concerning hydration

2.2

83.4

748

2353

SPAT1050

SPAT

Extensive neurological examination

2.7

82.3

510

1349

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

82.1

2109

21810

AA1CG, ,

SPAT

4.4

76.6

219

348

F0011, G301,

ICD-10 Finland

93.4

74.7

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

4.3

74.7

222

364

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

74.7

AA1BG, ,

SPAT

3.2

74.5

337

745

E86

ICD-10 Finland

Volume depletion

2.2

74.2

709

2290

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

74.1

1402

5726

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

73.6

5576

30585

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

73.3

728

2388

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.2

73.2

330

728

XF606, ,

SPAT

3.6

72.1

263

504

A27

ICPC

Fear of other disease NOS

1.9

70.1

1063

4057

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

34.1

69.4

G04CB01

ATC

finasteride; oral

1.5

69.0

3160

15863

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

68.2

1405

5873

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

67.7

3491

17904

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

65.8

638

2072

N30.0

ICD-10 Finland

Acute cystitis

1.4

65.2

3209

16306

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

65.0

1746

7811

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

64.9

1409

5971

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

64.5

1656

7326

N06AB04

ATC

citalopram; systemic

1.4

63.6

3362

17299

G04CA02

ATC

tamsulosin; oral

1.3

63.3

5935

33444

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.3

63.3

521

1579

A04AA02

ATC

granisetron; systemic, transdermal

0.4

62.6

260

4935

EB4VA, ,

NOMESCO Finland

0.5

62.3

488

7131

SPAT1263

SPAT

Sampling

1.3

61.6

7282

42330

R5110, ,

SPAT

1.5

61.0

1932

8972

N05AD03

ATC

melperone; systemic

2.8

60.9

338

843

SPAT1251

SPAT

Organisation of medication

1.9

60.5

809

2961

SPAT1167

SPAT

Insertion of urinary catheter

1.9

59.5

886

3359

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

28.3

59.5

F0024, G308,

ICD-10 Finland

464.5

58.5

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

84.5

57.6

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

57.5

129

3372

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

57.2

132

3395

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

3.9

57.1

190

341

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

56.4

2013

9583

N07AA05, ,

ATC

119.8

56.2

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

56.1

4375

37590

WX402

NOMESCO Finland

General anaesthesia

0.7

56.1

1657

16798

W0A10

NOMESCO Finland

Mapping of psychosocial situation

7.7

54.4

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

11.4

54.0

R33

ICD-10 Finland

Retention of urine

1.5

53.8

2089

10113

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

53.5

1044

4293

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

53.2

1762

8252

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

53.1

771

2899

R1210, ,

SPAT

4.3

52.8

155

252

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

51.9

3111

27851

WZC30

NOMESCO Finland

Teaching

0.6

51.8

1471

15060

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

51.0

5417

30843

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

26.6

50.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

50.7

2578

13122

TQW40, ,

SPAT

0.5

50.6

623

7867

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

49.9

5604

32121

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

49.7

2890

15044

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

49.5

1595

7419

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

49.0

1779

8488

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.0

49.0

156

271

A04AA01

ATC

ondansetron; systemic, rectal

0.5

48.9

511

6791

N17

ICPC

Vertigo/dizziness

1.4

48.9

2620

13448

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

21.7

48.8

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

136.5

48.7

WYA20, ,

SPAT

3.2

48.5

216

474

J01DB01

ATC

cefalexin; oral

1.3

48.1

13889

88898

F002, G308,

ICD-10 Finland

50.2

47.9

J01CA08

ATC

pivmecillinam; oral

1.3

46.2

6210

36314

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

46.1

567

2014

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

46.1

475

1580

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

46.0

2279

21090

P05

ICPC

Senility, feeling/behaving old

3.5

45.9

179

360

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

45.0

864

3534

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

44.3

1967

18558

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.5

44.2

312

882

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

44.2

2620

13661

EB1VA, ,

NOMESCO Finland

0.6

44.0

1041

11113

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

11.6

43.4

JN4AD

NOMESCO Finland

Body CT examination

0.7

43.0

1220

12530

F0012, G301,

ICD-10 Finland

120.2

42.5

SPAT1014

SPAT

Treatment of eyes

2.2

42.4

408

1321

R1250, ,

SPAT

1.9

42.4

562

2049

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

42.4

2841

25148

Z28

ICPC

Limited function/disability (Z)

3.7

42.2

149

280

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

42.1

163

3203

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

63.6

42.1

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

40.8

309

4586

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.0

40.6

129

224

P29

ICPC

Psychological sympt/compl other

1.9

40.1

543

1995

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

39.9

2779

14836

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

113.3

39.9

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.1

39.9

185

417

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

39.7

5562

32543

J01EA01

ATC

trimethoprim; systemic

1.3

39.3

4720

27113

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

39.2

182

3291

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

38.6

545

2031

L01BC06

ATC

capecitabine; oral

0.4

38.5

161

3051

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

38.3

4091

34150

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

38.1

845

3593

A10AB05

ATC

insulin aspart; parenteral

1.5

37.8

1311

6182

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.2

37.6

339

1069

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

37.5

835

3554

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

37.4

494

1800

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.9

37.3

486

1762

SPAT1284

SPAT

Extensive health certificate

2.1

37.3

380

1260

XF600, ,

SPAT

1.7

36.7

748

3109

-2, ,

ICPC

3.3

36.3

153

325

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

36.1

2032

18518

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

35.6

415

1448

N28

ICPC

Limited function/disability (N)

2.1

35.2

355

1173

C03DA01

ATC

spironolactone; oral

0.7

34.9

1715

15972

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

34.9

1897

9726

F22.0

ICD-10 Finland

Delusional disorder

2.4

34.8

249

709

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

276.2

34.4

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

4.3

34.4

159

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.7

34.3

2212

19770

F0013, G301,

ICD-10 Finland

+∞

34.2

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

33.9

1805

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

33.8

466

1723

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.0

33.6

114

LAITO, ,

NOMESCO Finland

8.0

33.6

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

33.5

1884

9709

D12

ICPC

Constipation

1.6

33.2

792

3429

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

33.2

1263

6067

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

33.2

967

9905

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

33.1

2651

14409

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

33.1

435

1583

A98

ICPC

Health maint/preventive medicine

1.3

33.0

15870

104577

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

32.8

831

3652

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

50.9

32.7

OAB41, ,

SPAT

2.6

32.2

202

540

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

8.8

31.9

C10AX09

ATC

ezetimibe; oral

0.7

31.6

1778

16233

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

31.2

1143

5448

F05.8

ICD-10 Finland

Other delirium

2.6

30.8

200

544

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

30.7

7216

44236

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

30.7

830

8638

S28

ICPC

Limited function/disability (S)

2.7

30.6

178

457

WPA10, ,

SPAT

3.9

30.5

175

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

30.5

438

1642

E0000UV, ,

ATC

1.2

30.5

6555

39841

W06

ICD-10 Finland

Fall involving bed

2.4

30.3

224

648

SPAT1262

SPAT

Handing over of treatment supplies

1.3

30.3

3196

17987

F0021, G308,

ICD-10 Finland

87.8

30.3

N29

ICPC

Neurological sympt/complt other

2.0

30.3

357

1251

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

30.2

7606

46904

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.8

29.9

475

1839

H02AB06

ATC

prednisolone; systemic

0.8

29.9

6836

53104

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

29.8

1278

12195

F0022, G308,

ICD-10 Finland

124.8

29.6

HA1RA, ,

SPAT

0.3

29.5

109

2188

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

29.4

517

2063

R06.0

ICD-10 Finland

Dyspnoea

0.8

29.2

3965

32433

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.3

29.2

103

2115

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

29.2

2353

12785

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

29.1

6881

42142

G04CB02

ATC

dutasteride; oral

1.4

28.8

1765

9211

P04

ICPC

Feeling/behaving irritable/angry

4.9

28.6

103

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

28.5

502

2003

XQ855, ,

SPAT

2.3

28.5

228

685

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

28.4

1206

5914

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.9

28.3

366

1325

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.3

28.0

114

237

XQ858, ,

SPAT

2.9

28.0

145

350

F0024, G301,

ICD-10 Finland

117.8

27.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

27.3

568

2376

Z2445

NOMESCO Finland

Psychologist

2.1

27.2

295

1003

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

27.1

563

2352

M01AH05

ATC

etoricoxib; oral

0.8

27.1

6799

52553

ZYB04, ,

SPAT

3.5

26.6

194

Z03

ICPC

Housing/neighbourhood problem

3.0

26.6

129

300

A10BK03

ATC

empagliflozin; oral

0.7

26.5

969

9523

Z51.5

ICD-10 Finland

Palliative care

1.3

26.5

2062

11138

N02AX02

ATC

tramadol; systemic, rectal

0.8

26.3

6024

46978

A01

ICPC

Pain general/multiple sites

1.3

26.2

1695

8912

L03AA13

ATC

pegfilgrastim; parenteral

0.5

26.1

191

2872

WW500

NOMESCO Finland

Blood transfusion

0.5

26.1

259

3505

R11

ICD-10 Finland

Nausea and vomiting

1.4

25.7

1444

7427

Z60.8

ICD-10 Finland

Other problems related to social environment

3.7

25.4

167

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

25.3

141

2355

K08.3

ICD-10 Finland

Retained dental root

1.4

25.2

1235

6209

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.9

25.2

132

321

F0023, G308,

ICD-10 Finland

+∞

25.2

F0004, G300,

ICD-10 Finland

+∞

25.2

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.1

25.0

112

248

F00, F03,

ICD-10 Finland

6.5

24.9

WF002

NOMESCO Finland

Radical radiotherapy

0.6

24.9

470

5310

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

24.8

760

3489

S01BC05

ATC

ketorolac; ophthalmic

1.5

24.6

866

4094

T08

ICPC

Weight loss

1.9

24.3

312

1128

SPAT1125

SPAT

Stoma care and guidance

1.8

24.3

402

1577

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

24.3

540

5869

G04BD08

ATC

solifenacin; oral

1.4

24.2

1330

6816

G04BD12

ATC

mirabegron; oral

1.3

24.0

2510

14077

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

23.8

446

1814

F009, F03,

ICD-10 Finland

8.6

23.7

C03CA01

ATC

furosemide; systemic

1.2

23.6

8252

51960

SDA03

NOMESCO Finland

Periodontal treatment

0.8

23.5

3536

28743

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

23.5

240

3218

A10AE04

ATC

insulin glargine; parenteral

1.3

23.5

1620

8596

K59.0

ICD-10 Finland

Constipation

1.4

23.4

1125

5635

KMAK, ,

NOMESCO Finland

1.2

23.3

6169

37955

T03

ICPC

Loss of appetite

3.3

23.2

199

A04AA55

ATC

palonosetron, combinations; systemic

0.3

23.0

1469

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

22.9

1556

13878

L75

ICPC

Fracture: femur

1.9

22.9

318

1181

A10BJ06

ATC

semaglutide; parenteral

0.5

22.7

165

2485

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

22.7

842

4022

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.9

22.6

117

283

M04AA01

ATC

allopurinol; systemic

0.8

22.6

2061

17700

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

22.5

1554

13831

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

22.4

238

804

R45.1

ICD-10 Finland

Restlessness and agitation

4.4

22.3

100

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.1

22.3

118

SPAT1260

SPAT

Consultation of another employee

1.2

22.3

2941

16924

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

22.2

790

3741

A78

ICPC

Infectious disease other/NOS

2.3

22.2

185

567

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

22.1

269

956

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.0

22.0

256

895

F009, G301,

ICD-10 Finland

180.5

22.0

B01AB10

ATC

tinzaparin; parenteral

0.7

22.0

996

9441

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

22.0

838

8178

A10BK01

ATC

dapagliflozin; oral

0.7

21.9

689

6967

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

21.8

568

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

93.5

21.8

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

21.7

2414

20277

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

21.7

1248

J01MA02

ATC

ciprofloxacin; systemic

1.2

21.7

7168

44827

E000001, ,

ATC

1.2

21.6

2761

15827

N07AA06, ,

ATC

+∞

21.6

P18

ICPC

Medication abuse

3.6

21.5

147

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

21.5

935

Y94.1

ICD-10 Finland

Accident in connection with service housing

6.2

21.4

SPAT1285

SPAT

Provision of consultation response

1.4

21.3

846

4096

C10AA07

ATC

rosuvastatin; oral

0.8

21.2

4090

32534

N03AX14

ATC

levetiracetam; systemic

1.7

21.1

417

1721

SPAT1236

SPAT

Informing family of child’s disability

1.8

20.9

323

1241

R54

ICD-10 Finland

Senility

2.4

20.9

156

455

G47.3

ICD-10 Finland

Sleep apnoea

0.8

20.8

1936

16605

ZXY02

NOMESCO Finland

Neuropsychologist

4.2

20.8

103

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

20.7

489

5248

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

20.7

1661

14507

Y94.0

ICD-10 Finland

Accident at home

1.8

20.7

344

1353

R03AC02

ATC

salbutamol; inhalant

0.9

20.6

6820

51962

R01AD59

ATC

mometasone, combinations; nasal

0.4

20.5

111

1874

L15

ICPC

Knee symptom/complaint

0.8

20.3

2807

23060

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.9

20.3

293

1103

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

20.3

1871

10321

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

20.2

1348

7113

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.8

20.2

309

1185

R01AD58

ATC

fluticasone, combinations; nasal

0.8

20.1

1385

12341

ZX120

NOMESCO Finland

Intravenous

0.7

20.0

877

8363

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

20.0

2676

15409

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

19.9

8709

55500

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.6

19.9

491

5215

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

19.8

130

2033

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

19.8

1065

9831

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

4.7

19.8

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

19.5

2161

12184

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

19.5

1563

A99

ICPC

Disease/condition unspecnature/site

1.3

19.5

1694

9273

H02AA02

ATC

fludrocortisone; oral

2.2

19.5

180

577

ZYY02, ,

SPAT

7.4

19.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

19.4

840

8024

N02BF01

ATC

gabapentin; oral

0.7

19.3

843

8044

P28

ICPC

Limited function/disability (P)

2.8

19.1

100

244

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

19.0

2855

16626

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

19.0

952

Z51.88

ICD-10 Finland

Other specified medical care

1.7

19.0

350

1418

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

18.9

735

3542

GD1AA, ,

SPAT

0.7

18.9

732

7126

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

18.8

3899

23412

T05

ICPC

Feeding problem of adult

2.7

18.7

108

278

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.6

18.7

416

1774

HA1AA

NOMESCO Finland

X-ray mammography

0.7

18.6

598

6024

R74

ICPC

Upper respiratory infection acute

0.8

18.4

1957

16548

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

18.4

530

2403

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

18.3

893

4484

ZXA00

NOMESCO Finland

Right side

1.2

18.3

4784

29272

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

18.3

420

4533

N06AX21

ATC

duloxetine; oral

1.3

18.3

1373

7369

L03AA02

ATC

filgrastim; parenteral

0.5

18.2

137

2035

U13

ICPC

Bladder symptom/complaint other

1.6

18.2

504

2264

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

18.2

129

1957

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

18.2

302

3519

R44.1

ICD-10 Finland

Visual hallucinations

2.4

18.1

129

369

ZXA05

NOMESCO Finland

Left side

1.2

18.1

4482

27301

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

18.1

2723

22218

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

18.1

190

2520

F0019, G309,

ICD-10 Finland

+∞

18.0

R4110, ,

SPAT

0.8

17.8

1387

12172

W0A10, ,

SPAT

7.4

17.7

JN4BD

NOMESCO Finland

Extensive body CT

0.8

17.7

1200

10727

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.0

17.7

F32

ICD-10 Finland

Depressive episode

1.6

17.6

422

1833

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

17.6

2180

12437

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

17.6

209

738

A10BH05

ATC

linagliptin; oral

1.3

17.5

1097

5736

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

76.2

17.4

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.9

17.4

229

837

S82

ICPC

Naevus/mole

0.8

17.4

1275

11280

Z75.0

ICD-10 Finland

Medical services not available in home

3.4

17.4

142

D82

ICPC

Teeth/gum disease

0.8

17.3

3137

25177

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

17.3

288

1135

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

17.2

495

5097

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

17.2

249

3006

OAB43, ,

SPAT

0.5

17.1

122

1847

XF606

NOMESCO Finland

Ortostatic test

2.1

17.1

180

608

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

17.1

252

3029

M25.5

ICD-10 Finland

Pain in joint

0.8

17.1

3084

24759

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

17.0

280

3271

G72.8

ICD-10 Finland

Other specified myopathies

1.7

17.0

313

1269

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

16.9

1507

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

16.9

4679

28732

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

16.8

1024

9286

ZX120, ,

SPAT

1.9

16.8

234

873

G04CA01

ATC

alfuzosin; oral

1.2

16.7

2376

13749

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

16.7

1371

7444

U28

ICPC

Limited function/disability (U)

1.9

16.7

221

810

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.5

16.7

128

1886

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

16.7

7876

50232

G04BD07

ATC

tolterodine; oral

1.4

16.7

981

5080

WZC30, ,

SPAT

0.7

16.6

690

6642

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.4

16.6

123

359

250, ,

Kela drug reimbursment

0.5

16.6

142

2012

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

16.5

2680

15711

C04AE01

ATC

ergoloid mesylates; systemic

2.1

16.5

160

524

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

16.4

399

4250

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.8

16.3

211

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

16.3

2415

14034

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

2.9

16.2

204

S09.9

ICD-10 Finland

Unspecified injury of head

1.8

16.2

258

1003

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.5

16.2

118

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

16.1

1232

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.7

16.1

277

1103

R45.5

ICD-10 Finland

Hostility

7.8

16.0

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

16.0

571

5642

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

16.0

130

1875

R18

ICD-10 Finland

Ascites

0.4

16.0

1500

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

16.0

840

4273

N80

ICPC

Head injury other

1.7

15.9

305

1252

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

5.3

15.9

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

15.8

1855

10514

F0020, G301,

ICD-10 Finland

38.1

15.8

SPAT1281

SPAT

Other administrative function

1.3

15.7

1125

5995

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

4.5

15.7

I95.9

ICD-10 Finland

Hypotension, unspecified

1.7

15.7

297

1215

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.4

15.6

116

339

A10BB12

ATC

glimepiride; oral

1.3

15.6

1521

8439

R2110

NOMESCO Finland

Giving the first information

1.4

15.6

735

3673

I67.4

ICD-10 Finland

Hypertensive encephalopathy

5.2

15.5

AA1AG, ,

SPAT

6.3

15.5

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

15.5

323

3562

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.6

15.5

105

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.9

15.4

215

803

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.6

15.4

208

2557

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

15.3

791

7350

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

15.2

568

2721

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.0

15.1

160

543

R4120, ,

SPAT

1.9

15.1

209

779

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.6

15.0

361

1572

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

15.0

620

5970

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.7

15.0

274

1111

K91

ICPC

Cerebrovascular disease

1.7

14.9

280

1143

-1, ,

ICPC

1.5

14.9

508

2389

SPAT1138

SPAT

Guidance concerning bowel function

1.7

14.8

271

1098

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

14.8

137

1890

ZYC01, ,

SPAT

1.3

14.8

1153

6217

NG1AA, ,

SPAT

0.6

14.8

205

2503

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

14.8

1215

6599

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

4.7

14.8

SPAT1104

SPAT

Monitoring of emergency patient

1.3

14.7

1054

5617

P03

ICPC

Feeling depressed

1.4

14.7

652

3222

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

14.7

733

3699

A11CC03

ATC

alfacalcidol; systemic

0.5

14.7

139

1902

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

14.6

735

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

14.6

295

3274

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

14.5

1404

S22.3

ICD-10 Finland

Fracture of rib

1.3

14.4

1101

5921

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

14.4

1057

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

3.5

14.4

104

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

14.4

704

F000, G300,

ICD-10 Finland

+∞

14.4

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

14.2

1883

10811

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

14.0

1355

D07AA02

ATC

hydrocortisone; topical

1.2

13.9

1703

9693

HA1AA, ,

SPAT

0.4

13.9

1321

SPAT1063

SPAT

Suctioning of mucus from airways

4.1

13.9

SPAT1153

SPAT

Removal of sutures

0.9

13.9

4497

34587

WW200, ,

SPAT

0.9

13.9

3537

27675

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

13.9

1693

9636

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

13.9

4071

25051

C10AA02

ATC

lovastatin; oral

1.3

13.8

888

4660

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.3

13.8

817

4235

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.5

13.8

260

R31

ICD-10 Finland

Unspecified haematuria

1.2

13.8

2145

12511

SPAT1081

SPAT

Cardiorespiratory global assessment

1.3

13.8

1030

5524

L02BG04

ATC

letrozole; oral

0.7

13.8

480

4761

N99

ICPC

Neurological disease other

1.9

13.7

191

714

Z11

ICPC

Compliance/being ill problem

2.3

13.7

110

334

SPAT1244

SPAT

Occupational therapy

1.9

13.6

170

613

A69.2

ICD-10 Finland

Lyme disease

0.7

13.6

430

4342

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

13.6

1012

5425

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

13.6

1346

XA400

NOMESCO Finland

EEG

2.5

13.6

246

F0001, G300,

ICD-10 Finland

+∞

13.5

S20.2

ICD-10 Finland

Contusion of thorax

1.4

13.5

707

3598

TK800

NOMESCO Finland

Hemodialysis

0.4

13.4

1388

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

13.4

2555

15181

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

13.4

742

3810

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

13.3

657

6151

L01CA04

ATC

vinorelbine; systemic

0.2

13.3

634

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

13.3

343

1519

R35

ICD-10 Finland

Polyuria

1.3

13.3

1225

6748

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

13.3

933

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

13.2

382

3924

R4190

NOMESCO Finland

Nutritional therapy

0.5

13.2

135

1800

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.4

13.1

620

3100

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

13.1

774

7053

TDA90, ,

SPAT

0.7

13.1

723

6651

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

13.1

374

3849

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.1

12.9

347

XX2RW, ,

NOMESCO Finland

0.3

12.9

824

G40

ICD-10 Finland

Epilepsy

2.3

12.9

101

303

S06.3

ICD-10 Finland

Focal brain injury

1.8

12.9

199

768

I50.1

ICD-10 Finland

Left ventricular failure

0.7

12.9

706

6504

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

12.8

506

2451

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.4

12.8

977

ZYY01, ,

SPAT

3.0

12.8

142

C01DA14

ATC

isosorbide mononitrate; oral

1.1

12.8

4246

26338

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.6

12.8

225

2577

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

12.8

603

S18

ICPC

Laceration/cut

0.9

12.7

7114

52943

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

12.7

415

4166

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

2.9

12.7

150

A10AE05

ATC

insulin detemir; parenteral

1.4

12.7

735

3800

P19

ICPC

Drug abuse

3.5

12.7

WX723

NOMESCO Finland

CPAP therapy

0.5

12.6

152

1929

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

12.6

457

4501

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

12.6

290

3122

F009, G308,

ICD-10 Finland

+∞

12.6

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.7

12.5

243

1003

Z01.2

ICD-10 Finland

Dental examination

0.9

12.5

4645

35449

ZYY02

NOMESCO Finland

Contact between professionals and family members

6.6

12.5

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.0

12.5

N06AX16

ATC

venlafaxine; oral

1.3

12.4

1233

6853

A12AA04

ATC

calcium carbonate; oral

0.4

12.4

1155

F0021, G301,

ICD-10 Finland

39.2

12.4

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

103.9

12.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

12.3

759

N07

ICPC

Convulsion/seizure

3.8

12.3

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

12.3

906

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

12.3

236

972

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.0

12.2

129

438

T82

ICPC

Obesity

0.5

12.2

1283

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

12.2

1585

13161

H91.1

ICD-10 Finland

Presbycusis

1.2

12.2

1674

9638

SPAT1127

SPAT

Enema

1.9

12.2

171

641

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

12.2

425

4215

R03BA08

ATC

ciclesonide; inhalant

0.7

12.2

609

5687

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.3

12.2

698

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

2.7

12.1

178

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.2

12.1

106

335

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

2.9

12.1

147

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

12.1

532

L01AX03

ATC

temozolomide; systemic

0.1

11.9

273

SPAT1042

SPAT

Guidance concerning balance maintenance

2.2

11.9

104

328

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.5

11.9

216

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.2

11.9

1528

8741

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.9

11.9

167

627

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

11.9

1191

Z08

ICPC

Social welfare problem

1.9

11.9

143

510

WX290

NOMESCO Finland

Other blockage of nerve

0.9

11.9

3709

28651

UKC02

NOMESCO Finland

Cystoscopy

1.2

11.8

3376

20699

SPAT1058

SPAT

PEF monitoring instruction

0.8

11.8

763

6870

NF3AA

NOMESCO Finland

Femur X-ray examination

1.5

11.8

391

1832

U29

ICPC

Urinary symptom/complaint other

1.4

11.8

518

2560

U05

ICPC

Urination problems other

1.3

11.8

987

5375

R40.2

ICD-10 Finland

Coma, unspecified

1.9

11.7

151

551

F0002, G300,

ICD-10 Finland

+∞

11.7

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

11.7

542

5119

A05

ICPC

Feeling ill

1.4

11.7

574

2892

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.6

789

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

11.6

287

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

11.5

2461

19558

G03DC02

ATC

norethisterone; oral

0.8

11.5

704

6386

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

11.5

1311

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

11.5

563

L08

ICPC

Shoulder symptom/complaint

0.9

11.5

2575

20388

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

11.5

171

2043

N05AX12

ATC

aripiprazole; systemic

1.9

11.5

156

580

L01CB01

ATC

etoposide; systemic

0.1

11.5

331

S01

ICD-10 Finland

Open wound of head

1.8

11.4

188

741

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

4.0

11.4

H04AA01

ATC

glucagon; nasal, parenteral

2.0

11.4

136

483

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

5.7

11.4

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

2.3

11.4

263

115

Kela drug reimbursment

Breast cancer

0.8

11.4

728

6563

WX722

NOMESCO Finland

PEEP

0.7

11.3

359

3621

D19

ICPC

Teeth/gum symptom/complaint

0.9

11.3

2559

20245

M02AA07

ATC

piroxicam; topical

1.1

11.3

6195

39596

R44

ICPC

Respiratory, Preventive immunization/medic

1.6

11.3

287

1269

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.1

11.3

5597

35565

F30.1

ICD-10 Finland

Mania without psychotic symptoms

5.4

11.3

SDA05

NOMESCO Finland

Very demanding periodontal treatment

0.7

11.3

320

3297

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.6

11.3

246

1048

WYA30, ,

SPAT

2.3

11.3

256

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

11.2

343

1582

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

11.2

581

2955

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.2

11.2

100

319

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

5.1

11.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

11.1

3892

29863

G04BD10

ATC

darifenacin; oral

2.0

11.1

127

445

SGA01

NOMESCO Finland

Emergency treatment

0.8

11.1

785

6978

L57.0

ICD-10 Finland

Actinic keratosis

0.8

11.0

1842

14942

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

11.0

1509

12465

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.7

11.0

214

886

R03BB04

ATC

tiotropium bromide; inhalant

0.8

10.9

1464

12118

D10

ICPC

Vomiting

1.5

10.9

360

1687

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

10.8

1069

9136

ZXD35

NOMESCO Finland

Usual procedure

1.4

10.8

456

2237

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

10.8

420

4085

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

10.8

1051

5828

SPAT1240

SPAT

Therapeutic discussion

1.3

10.8

756

4019

F0009, G309,

ICD-10 Finland

+∞

10.8

F0014, G309,

ICD-10 Finland

+∞

10.8

P99

ICPC

Psychological disorders other

1.8

10.8

174

683

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.5

10.7

312

1423

J01FA10

ATC

azithromycin; systemic

0.9

10.7

5931

44297

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

1.8

10.7

168

654

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.8

10.7

671

6062

B01AA03

ATC

warfarin; systemic

1.1

10.7

4698

29620

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.3

10.7

839

4532

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

10.7

317

3236

K03.00

ICD-10 Finland

Approximal wear

0.7

10.7

398

3896

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

10.7

202

2270

N05AH02

ATC

clozapine; systemic

2.3

10.6

250

F0022, G301,

ICD-10 Finland

48.5

10.6

N18

ICPC

Paralysis/weakness

1.5

10.6

338

1572

U08

ICPC

Urinary retention

1.4

10.6

403

1941

F0001, G301,

ICD-10 Finland

90.0

10.6

Q90.9

ICD-10 Finland

Down syndrome, unspecified

90.0

10.6

R03BB01

ATC

ipratropium bromide; inhalant

0.7

10.6

523

4891

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

10.6

4423

33579

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

1.8

10.6

150

566

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

10.5

994

5494

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.6

10.5

177

2048

Z74.1

ICD-10 Finland

Need for assistance with personal care

6.1

10.5

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.4

10.5

1078

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.5

10.5

110

1451

R053, ,

ICD-10 Finland

0.5

10.5

102

1377

SPAT1325

SPAT

Vaccination

1.1

10.4

6476

41641

R44.0

ICD-10 Finland

Auditory hallucinations

2.5

10.4

197

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.6

10.4

187

2126

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.4

2267

13613

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

10.3

954

F06.0

ICD-10 Finland

Organic hallucinosis

2.8

10.3

137

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

9.5

10.3

F01

ICD-10 Finland

Vascular dementia

2.2

10.3

298

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

10.3

1203

R03AK08

ATC

formoterol and beclometasone; inhalant

0.7

10.3

270

2823

R00.2

ICD-10 Finland

Palpitations

0.7

10.3

528

4907

S01EX03, ,

ATC

1.4

10.2

458

2275

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.7

10.2

415

3999

D06BB10

ATC

imiquimod; topical

0.7

10.2

513

4780

N03AF02

ATC

oxcarbazepine; oral

1.5

10.1

367

1752

Z51.0

ICD-10 Finland

Radiotherapy session

0.4

10.1

966

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

3.3

10.1

128

Kela drug reimbursment

Cancers of female genital organs

0.5

10.1

1138

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.8

10.1

143

540

R03DA04

ATC

theophylline; systemic, rectal

0.8

10.1

735

6509

TPH04, ,

SPAT

1.7

10.1

170

677

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.4

10.0

389

1883

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

10.0

483

4529

OAB48, ,

SPAT

0.6

10.0

182

2062

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

10.0

831

SGB30

NOMESCO Finland

Other complicated root filling

0.7

9.9

352

3474

S01.7

ICD-10 Finland

Multiple open wounds of head

2.0

9.9

104

354

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

9.9

356

1698

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

9.9

512

2605

EBA00

NOMESCO Finland

Extraction of tooth

1.1

9.9

4754

30114

SPAT1255

SPAT

Intravenous administration of medicine

1.2

9.9

1044

5850

A06AH03

ATC

naloxegol; oral

0.4

9.8

963

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.8

1106

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.5

9.8

1077

SPAT1111

SPAT

Planning of analgesia

1.7

9.8

171

688

G03CA04

ATC

estriol; systemic, vaginal

1.2

9.8

1409

8154

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.1

9.8

253

C09CA06

ATC

candesartan; oral

0.9

9.7

2850

22153

R12

ICD-10 Finland

Heartburn

0.8

9.7

638

5728

TGC00

NOMESCO Finland

Bronchial lavation

0.6

9.7

175

1989

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

9.7

474

4439

L02BG06

ATC

exemestane; oral

0.5

9.7

1036

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

9.7

463

2324

AA1AA

NOMESCO Finland

Head X-ray examination

1.9

9.7

126

463

C10AA03

ATC

pravastatin; oral

1.2

9.7

1380

7979

C09AA05

ATC

ramipril; oral

1.1

9.6

5196

33116

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.6

9.6

165

1895

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.0

9.6

111

392

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

9.6

257

2673

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.3

9.6

218

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

9.6

693

Angiography of the heart and coronary arteries

1.2

9.6

1440

8369

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

9.5

258

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.2

9.5

245

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.3

9.5

638

T90.5

ICD-10 Finland

Sequelae of intracranial injury

1.9

9.5

119

432

R2110, ,

SPAT

5.4

9.5

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

9.4

130

1582

YX9AW, ,

NOMESCO Finland

0.2

9.4

306

S32.5

ICD-10 Finland

Fracture of pubis

1.7

9.4

180

744

R01AD12

ATC

fluticasone furoate; nasal

0.9

9.4

2275

17920

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.7

9.3

158

630

SPAT1310

SPAT

Counselling related to known health issue

1.1

9.3

4842

30785

G03AC03

ATC

levonorgestrel; oral, implant

0.7

9.3

285

2888

L76

ICPC

Fracture: other

1.4

9.3

511

2626

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

5.5

9.3

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.3

9.2

628

3329

N05AB03

ATC

perphenazine; systemic, rectal

1.4

9.2

344

1653

K05.30

ICD-10 Finland

Periodontitis complex

0.8

9.2

1481

12062

L04AX03

ATC

methotrexate; systemic

0.8

9.2

748

6535

A49

ICPC

General and Unspecified, Other preventive procedure

1.9

9.2

116

422

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.4

9.2

679

B04AB02, ,

ATC

1.4

9.2

410

2037

M03BX02

ATC

tizanidine; oral

0.9

9.2

6862

50569

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.2

9.1

471

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.4

9.1

666

T93

ICPC

Lipid disorder

0.8

9.1

693

6100

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

9.1

846

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

9.1

182

2014

WVA40, ,

SPAT

2.0

9.1

106

376

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.2

9.1

1159

6629

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

9.0

5906

43830

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.5

9.0

300

1410

A06

ICPC

Fainting/syncope

1.6

9.0

219

961

N05CD07

ATC

temazepam; oral

1.2

9.0

2359

14355

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

9.0

928

5185

F38

ICPC

Eye, Other laboratory test NEC

0.5

9.0

102

1309

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.8

8.9

817

7034

J01FA09

ATC

clarithromycin; systemic

0.9

8.9

3021

23261

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

5.0

8.8

G04BX04, ,

ATC

1.5

8.8

307

1457

JN6AD

NOMESCO Finland

CT of torso and neck

0.5

8.8

1146

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

8.8

285

1334

WX199

NOMESCO Finland

Other local analgesia

0.7

8.7

318

3122

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

3.2

8.7

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

8.7

181

1987

SPAT1097

SPAT

Recording of ECG

1.1

8.7

2582

15848

XKD00

NOMESCO Finland

Uroflowmetry

1.1

8.7

3242

20207

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

0.5

8.7

888

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

8.6

1621

13031

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.6

8.6

185

2015

E66

ICD-10 Finland

Obesity

0.6

8.6

134

1576

ZYY79, ,

SPAT

2.1

8.6

279

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

8.6

476

Z43.5

ICD-10 Finland

Attention to cystostomy

1.8

8.6

134

523

A04AD12

ATC

aprepitant; systemic

0.5

8.6

884

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

8.6

102

1291

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.2

8.6

243

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.5

8.5

295

1398

A02

ICPC

Chills

2.0

8.5

346

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

8.5

5716

36809

N18.0

ICD-10 Finland

End-stage renal disease

0.4

8.5

842

K80

ICPC

Cardiac arrhythmia NOS

0.8

8.5

959

8074

K90

ICPC

Stroke/cerebrovascular accident

1.3

8.5

562

2972

JN3AD

NOMESCO Finland

Abdominal CT examination

0.8

8.4

1530

12333

L04AX01

ATC

azathioprine; systemic

0.7

8.4

220

2298

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.3

8.4

187

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.2

8.4

906

5088

359

Kela drug reimbursment

Mirabegroni

1.9

8.4

103

372

A01AB09

ATC

miconazole; local oral

1.2

8.4

1334

7793

L03

ICPC

Low back symptom/complaint

0.9

8.4

3261

24915

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.6

8.4

164

1823

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.4

8.4

700

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.4

8.4

710

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

8.4

1244

10202

SPF30

NOMESCO Finland

Relining of denture

1.4

8.4

316

1524

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.1

8.4

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

8.3

998

8354

R5120

NOMESCO Finland

Preparation of an aid

1.3

8.3

511

2672

D17

ICPC

Incontinence of bowel

1.6

8.3

183

785

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.8

8.3

517

4670

B03XA02

ATC

darbepoetin alfa; parenteral

0.6

8.3

154

1733

WZC15, ,

NOMESCO Finland

0.3

8.3

466

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

8.3

1667

9939

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

8.3

712

3896

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.8

8.3

954

8016

-31

ICPC

Medical examin/health eval partial

1.2

8.3

1050

6002

T11

ICPC

Dehydration

3.0

8.3

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

8.3

385

3627

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.1

8.3

4736

30242

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

0.8

8.2

495

4494

H02.3

ICD-10 Finland

Blepharochalasis

0.8

8.2

687

5981

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

8.2

231

2378

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.0

8.2

298

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.7

8.2

264

2649

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.6

8.2

209

928

S16

ICPC

Bruise/contusion

1.3

8.2

516

2707

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

0.3

8.2

592

Z60.2

ICD-10 Finland

Living alone

4.2

8.2

Z73.6

ICD-10 Finland

Limitation of activities due to disability

1.8

8.2

125

485

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

8.2

370

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.0

8.2

Z49.0

ICD-10 Finland

Preparatory care for dialysis

0.4

8.1

600

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

8.1

5872

37929

U70

ICPC

Pyelonephritis/pyelitis

1.6

8.1

199

876

N43

ICPC

Neurological, Other diagnostic procedure

2.1

8.1

267

L04AA06

ATC

mycophenolic acid; systemic

0.4

8.1

759

F0003, G300,

ICD-10 Finland

+∞

8.1

F0010, G308,

ICD-10 Finland

+∞

8.1

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

8.1

1280

10436

L02BB04

ATC

enzalutamide; oral

0.5

8.1

863

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.3

8.0

725

3990

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.5

8.0

1176

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.9

8.0

2010

15808

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.4

8.0

324

1583

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

0.5

8.0

1103

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.7

8.0

161

675

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.9

8.0

108

403

B01AC07

ATC

dipyridamole; systemic

1.2

8.0

1110

6403

R02

ICPC

Shortness of breath/dyspnoea

0.9

8.0

1845

14596

NG1BG, ,

SPAT

0.3

8.0

542

SAD01, ,

SPAT

3.9

8.0

180

Kela drug reimbursment

Interferon alfa

0.2

8.0

247

HA1AE, ,

SPAT

0.4

7.9

772

A07

ICPC

Coma

2.1

7.9

251

T68

ICD-10 Finland

Hypothermia

2.1

7.9

242

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

3.0

7.9

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.4

7.9

591

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.5

7.9

268

1267

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.7

7.9

215

2224

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

7.9

517

NA3BG, ,

SPAT

0.6

7.9

111

1338

N05CD08

ATC

midazolam; nasal, systemic

1.4

7.9

366

1833

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

7.8

939

L90

ICPC

Osteoarthrosis of knee

0.8

7.8

783

6678

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.1

7.8

257

IGV01

NOMESCO Finland

Psychiatric network contact

2.6

7.8

122

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.8

7.8

931

7791

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.9

7.8

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

1.6

7.7

172

741

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

0.8

7.7

637

5550

ZYY01

NOMESCO Finland

Contact between professionals

3.4

7.7

C10AA04

ATC

fluvastatin; oral

1.2

7.6

1760

10605

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.7

7.6

248

2481

WX111

NOMESCO Finland

Local infiltration anesthesia

0.7

7.6

309

2975

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.5

7.6

798

R41.2

ICD-10 Finland

Retrograde amnesia

3.4

7.6

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.4

7.6

413

2121

SPAT1394

SPAT

Counselling and guidance related to living conditions

2.4

7.6

157

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

7.6

431

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.5

7.6

992

IHZ01, ,

SPAT

2.2

7.6

219

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

7.6

338

3202

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.4

7.5

149

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.6

7.5

115

1357

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

7.5

636

5527

OAA80, ,

SPAT

0.3

7.5

494

Z01.8

ICD-10 Finland

Other specified special examinations

1.1

7.5

3264

20513

SPAT1377

SPAT

Polysomnography

0.6

7.5

149

1648

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

0.8

7.5

450

4081

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

7.5

1010

8355

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

0.2

7.5

223

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.3

7.5

534

2856

191

Kela drug reimbursment

Erlotinib

0.1

7.4

174

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.4

7.4

397

2036

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

0.4

7.4

702

R05

ICPC

Cough

0.9

7.4

2842

21746

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

2.1

7.4

249

C10AA05

ATC

atorvastatin; oral

1.1

7.4

8018

52705

OAB73, ,

SPAT

2.2

7.4

208

HMAK, ,

NOMESCO Finland

0.8

7.4

808

6821

M05BA02

ATC

clodronic acid; systemic

0.3

7.3

412

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

1.7

7.3

145

606

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

7.3

148

622

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

7.3

3718

23566

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.8

7.3

547

4823

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.5

7.3

907

S01.2

ICD-10 Finland

Open wound of nose

1.5

7.3

199

899

W18

ICD-10 Finland

Other fall on same level

1.9

7.3

356

JAH01

NOMESCO Finland

Laparoscopy

0.7

7.3

228

2295

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.8

7.3

105

401

F32.0

ICD-10 Finland

Mild depressive episode

1.5

7.3

200

906

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

8.5

7.3

S82.0

ICD-10 Finland

Fracture of patella

1.5

7.3

229

1068

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.5

7.2

950

M76.6

ICD-10 Finland

Achilles tendinitis

0.7

7.2

277

2691

322

Kela drug reimbursment

Sunitinib

0.0

7.2

127

SPAT1064

SPAT

Management of tracheostomy stoma

3.1

7.2

TPH07

NOMESCO Finland

Cathetrisation of artery

0.9

7.2

1493

11911

SAD02, ,

SPAT

6.9

7.2

A84

ICPC

Poisoning by medical agent

4.5

7.2

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

4.5

7.2

F0014, G308,

ICD-10 Finland

+∞

7.2

F0024, G309,

ICD-10 Finland

+∞

7.2

F0012, G308,

ICD-10 Finland

+∞

7.2

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

1.8

7.2

109

423

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.4

7.2

664

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

1.8

7.2

101

383

N05AL01

ATC

sulpiride; systemic

1.6

7.2

174

766

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.3

7.2

663

3663

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.2

7.1

1342

7957

F0023, G301,

ICD-10 Finland

62.3

7.1

Z27

ICPC

Fear of a social problem

2.5

7.1

132

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

7.1

4407

28218

TFP34

NOMESCO Finland

Electrophysiological investigation

0.6

7.1

144

1585

OAB95, ,

SPAT

0.3

7.1

469

OAB71, ,

SPAT

0.3

7.1

490

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

2.2

7.1

193

H02AB07

ATC

prednisone; oral

0.9

7.1

1708

13476

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

2.1

7.1

239

D22

ICD-10 Finland

Melanocytic naevi

0.7

7.1

187

1943

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.6

7.0

1139

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

0.2

7.0

267

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

7.0

695

3870

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

0.5

7.0

1048

P71

ICPC

Organic psychosis other

4.9

7.0

G04BD09

ATC

trospium; oral

1.3

7.0

414

2157

C01BD01

ATC

amiodarone; systemic

0.7

7.0

294

2810

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.4

7.0

343

1737

R999, ,

ICD-10 Finland

2.8

6.9

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.5

6.9

230

1084

P27

ICPC

Fear of mental disorder

1.9

6.9

289

T89

ICPC

Diabetes insulin dependent

1.4

6.9

318

1592

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.4

6.9

269

1308

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.8

6.9

1058

8651

C08CA13

ATC

lercanidipine; oral

0.9

6.9

2212

17118

ZX095

NOMESCO Finland

Combined chemoradiotherapy

0.2

6.9

263

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.3

6.9

429

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

1.4

6.9

322

1617

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

0.4

6.9

681

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.1

6.9

179

ZXD20

NOMESCO Finland

Day surgery

1.2

6.9

1619

9774

NK4EA, ,

SPAT

0.1

6.9

180

E87.6

ICD-10 Finland

Hypokalaemia

1.3

6.9

527

2847

D11

ICPC

Diarrhoea

1.2

6.9

1203

7093

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

1.9

6.8

339

G04BD04

ATC

oxybutynin; oral, transdermal

1.2

6.8

961

5553

UJF32, ,

SPAT

0.7

6.8

203

2061

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.3

6.8

580

3175

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

0.4

6.8

580

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

6.8

9126

60443

TQW40

NOMESCO Finland

Remowal of suture of skin

0.8

6.8

585

5068

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.9

6.8

3610

27143

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

3.8

6.8

N05AX16

ATC

brexpiprazole; oral

3.8

6.8

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

0.6

6.8

124

1395

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

6.8

324

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.7

6.7

270

2601

PJA10

NOMESCO Finland

Exploration of lymph nodes

0.5

6.7

752

WVA30, ,

SPAT

0.8

6.7

626

5378

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.3

6.7

656

3648

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

6.7

12649

84908

SPAT1142

SPAT

Minor procedure on teeth, gums, mouth and pharynx

2.5

6.7

115

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

0.5

6.7

816

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

0.6

6.7

154

1647

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

1.4

6.7

258

1252

D07AC01

ATC

betamethasone; topical

1.1

6.7

5473

35490

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

2.6

6.7

103

QXA70, ,

SPAT

0.5

6.7

674

K31

ICPC

Cardiovascular, Medical examin/health eval partial

1.7

6.7

111

443

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.6

6.7

1157

QDB10, ,

SPAT

0.7

6.7

215

2151

JAH00

NOMESCO Finland

Laparotomy

0.7

6.7

225

2232

Z09

ICPC

Legal problem

2.0

6.7

269

G03FB08

ATC

dydrogesterone and estrogen; systemic

0.7

6.7

203

2051

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

0.6

6.7

149

1602

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

0.2

6.7

248

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.4

6.6

504

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

0.6

6.6

1093

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

0.7

6.6

169

1768

G04BE04

ATC

yohimbine; oral

1.6

6.6

154

672

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.2

6.6

1118

6570

Z00.0

ICD-10 Finland

General medical examination

1.1

6.6

2897

18206

F22.8

ICD-10 Finland

Other persistent delusional disorders

3.1

6.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.9

6.6

4819

35699

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.7

6.6

162

1709

S72.3

ICD-10 Finland

Fracture of shaft of femur

1.6

6.6

146

629

B03XA01

ATC

erythropoietin; parenteral

0.5

6.6

689

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1.7

6.6

132

555

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

6.6

4211

26994

N02AJ13

ATC

tramadol and paracetamol; systemic

0.6

6.6

121

1360

WX730

NOMESCO Finland

Conventional respirator

0.6

6.6

1134

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

0.7

6.6

316

2955

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

6.5

1216

7205

SPA02

NOMESCO Finland

Preparation for dental prosthetics

0.7

6.5

219

2174

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.9

6.5

305

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

6.5

588

5068

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.6

6.5

137

583

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

0.2

6.5

242

A23

ICPC

Risk factor NOS

1.2

6.5

920

5319

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.4

6.5

509

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.7

6.5

246

2391

OAB44, ,

SPAT

0.8

6.5

678

5751

ZX112

NOMESCO Finland

Subcutaneous

0.6

6.5

136

1483

IGP01

NOMESCO Finland

Psychiatric family contact

2.5

6.5

109

N02BF02

ATC

pregabalin; oral

0.8

6.5

517

4518

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.3

6.5

496

2680

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.8

6.5

485

4270

J01CA04

ATC

amoxicillin; systemic

1.1

6.5

12496

83898

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

0.2

6.5

253

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.8

6.5

804

6699

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.1

6.5

5413

35132

GD1QA, ,

SPAT

2.3

6.4

152

SAE03, ,

NOMESCO Finland

0.1

6.4

155

A08.3

ICD-10 Finland

Other viral enteritis

2.2

6.4

161

LCA06

NOMESCO Finland

Biopsy of endometrium

0.8

6.4

679

5750

K86

ICPC

Hypertension uncomplicated

0.9

6.4

2046

15839

N04BD02

ATC

rasagiline; oral

0.4

6.4

565

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

0.6

6.4

149

1587

XW000

NOMESCO Finland

Bone marrow biopsy

0.8

6.4

406

3650

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.2

6.4

1548

9366

X59.0

ICD-10 Finland

Exposure to unspecified factor causing fracture

3.6

6.4

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.6

6.3

153

674

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.3

6.3

429

2280

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

0.4

6.3

462

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.8

6.3

531

4613

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.7

6.3

207

2063

S15

ICPC

Foreign body in skin

0.8

6.3

630

5369

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.3

575

3174

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

0.7

6.3

222

2184

H02BX01

ATC

methylprednisolone, combinations; systemic

1.2

6.3

868

5008

F0009, G301,

ICD-10 Finland

+∞

6.3

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.8

6.3

471

4147

R21

ICPC

Throat symptom/complaint

0.9

6.3

1318

10503

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.3

1462

8819

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.1

6.3

6865

45044

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

0.1

6.3

150

GX1B5, ,

SPAT

0.4

6.3

459

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

0.2

6.3

319

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.7

6.3

195

1960

J01

ICD-10 Finland

Acute sinusitis

0.7

6.2

224

2196

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

0.3

6.2

341

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.5

6.2

170

771

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.8

6.2

404

3621

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

2.2

6.2

177

193

Kela drug reimbursment

Rasagiline

0.3

6.2

426

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

0.6

6.2

106

1211

B02

ICD-10 Finland

Zoster [herpes zoster]

0.8

6.2

363

3298

N50

ICPC

Neurological, Medication/prescr/renewal

4.4

6.2

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

0.7

6.2

215

2118

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

0.9

6.2

2549

19435

JAL00

NOMESCO Finland

Biopsy of peritoneum

0.3

6.2

248

K64.0

ICD-10 Finland

First degree haemorrhoids

0.6

6.2

102

1174

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

0.7

6.1

246

2367

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

0.5

6.1

846

M02AA10

ATC

ketoprofen; topical

1.1

6.1

2347

14635

L02BA03

ATC

fulvestrant; parenteral

0.3

6.1

391

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.8

6.1

941

7688

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

0.6

6.1

1023

SFA20

NOMESCO Finland

Two-surface restoration

0.9

6.1

6098

44598

P76

ICPC

Depressive disorder

1.3

6.1

376

1973

D01AC02

ATC

miconazole; topical

1.2

6.1

1155

6856

HAB99

NOMESCO Finland

Other partial excision of mammary gland

0.6

6.1

125

1368

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

0.8

6.1

568

4874

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.7

6.1

101

404

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

0.4

6.1

483

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

0.6

6.1

1048

C09DX04

ATC

valsartan and sacubitril; oral

0.5

6.1

620

Z00.8

ICD-10 Finland

Other general examinations

1.2

6.1

994

5828

IHZ07, ,

SPAT

2.0

6.1

216

JAL30

NOMESCO Finland

Omentectomy

0.4

6.1

571

K88

ICPC

Postural hypotension

1.5

6.0

168

765

XCW10, ,

SPAT

0.4

6.0

441

EC1VA, ,

NOMESCO Finland

0.7

6.0

261

2480

P69

ICPC

Psychological, Other reason for encounter NEC

3.7

6.0

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

0.7

6.0

201

1995

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.6

6.0

124

526

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.3

6.0

391

2068

NG2AA

NOMESCO Finland

Patella X-ray examination

0.7

6.0

221

2156

Z49.2

ICD-10 Finland

Other dialysis

0.3

6.0

333

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1137

2184

3.76

313.14

1.2

1.3

502.08

601.81

mg/l

2.89

1055

2093

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1116

517

15.78

307.65

1.0

53.10

34.34

ng/l

21.92

817

319

(3019309) Folate [Moles/volume] in Red Blood Cells

7487

27152

2.47

307.65

1.9

1.8

1165.62

1148.27

nmol/l

0.81

5620

19925

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1115

517

15.76

307.65

1.0

573.91

810.29

ng/l

20.60

809

312

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11783

59209

1.95

307.65

2.7

2.3

92.75

94.04

pmol/l

2.00

6432

31023

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1104

521

15.48

307.65

1.0

398.68

290.86

ng/l

7.35

816

330

(3021960) Folate [Moles/volume] in Serum or Plasma

9414

41109

2.12

307.65

1.9

1.8

20.40

20.23

nmol/l

0.40

8226

33962

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6369

27934

1.86

307.27

2.8

3.2

2.46

2.47

mmol/l

18.81

5680

24749

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1029

1861

3.98

307.24

1.3

1.4

322.07

2476.65

e6/l

1.17

797

1502

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1020

1842

3.99

305.11

1.2

1.4

12.38

27.79

e6/l

1.38

755

1395

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1032

1897

3.92

301.49

1.2

3.84

mmol/l

0.00

987

1787

(3015377) Calcium [Moles/volume] in Serum or Plasma

8801

44554

1.67

240.88

2.7

3.5

2.35

mmol/l

0.18

7862

39566

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5956

28308

1.65

197.15

1.9

1.8

5798138.68

29463687.33

pmol/l

6.64

4864

22282

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9625

51491

1.58

194.78

2.3

2.4

77.94

81.33

nmol/l

23.46

8346

44563

(3031040) Bacteria [#/volume] in Urine by Automated count

13629

79827

1.60

178.31

6.4

5.8

2997.74

1748.42

e6/l

1.49

359

1283

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10973

61279

1.54

175.77

5.1

6.7

1.22

1.21

mmol/l

21.88

9962

55896

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11974

68495

1.54

168.37

5.7

7.4

1.22

1.21

mmol/l

40.22

10243

58250

(3024561) Albumin [Mass/volume] in Serum or Plasma

10717

59914

1.52

166.78

4.0

5.0

34.77

34.19

g/l

21.76

9770

55438

(3009466) Valproate [Moles/volume] in Serum or Plasma

588

1126

3.69

161.41

3.5

4.1

318.07

330.80

umol/l

1.17

490

956

(3018418) pH of Serum or Plasma

7801

41281

1.51

152.16

3.2

4.4

7.40

0.87

5829

30025

(3026008) Bacteria identified in Urine by Culture

8436

45625

1.49

146.13

3.9

3.8

—

(3023410) Appearance of Cerebral spinal fluid

449

760

4.16

145.10

1.2

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5270

25831

1.56

144.09

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3888

17811

1.64

140.34

2.0

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4121

19310

1.60

135.03

2.0

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4456

41176

0.67

105.58

1.8

2.0

1.21

1.26

mmol/l

3.83

3798

32753

(3019150) Specific gravity of Urine by Refractometry

5151

26788

1.45

98.31

5.2

5.0

1.02

1.13

kg/l

0.81

3531

18498

(3023368) Bacteria identified in Blood by Culture

7485

41869

1.38

93.12

4.0

4.6

—

(40768804) Tissue Pathology biopsy report

5186

45743

0.71

90.49

2.3

2.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15940

101811

1.45

80.75

21.4

21.8

31.18

28.57

mg/l

15.29

14098

87942

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14929

94301

1.40

79.80

5.6

5.7

2.03

2.10

mu/l

5.43

13541

84480

(3016018) Differential panel - Cerebral spinal fluid

408

976

2.93

79.10

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12722

78499

1.35

77.06

4.1

4.5

15.25

15.26

pmol/l

0.26

11347

69702

(3012516) Albumin [Mass/volume] in Urine

5195

44650

0.73

71.56

3.0

3.5

55.56

51.87

mg/l

0.36

3422

28703

(3009508) Creatinine [Moles/volume] in Urine

5249

44900

0.74

69.35

3.0

3.5

6.85

6.71

mmol/l

1.73

4294

36683

(3037467) Urinalysis macro (dipstick) panel - Urine

12829

79784

1.33

69.09

5.5

5.4

2.15

106.58

0.49

127

(4035726) Immunohistochemistry procedure

1001

11786

0.57

64.40

1.3

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

12256

76072

1.31

64.12

29.4

29.5

329.99

330.19

g/l

1.63

12108

75498

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6643

37986

1.32

64.10

2.4

2.5

2.84

3.06

mg/l

10.79

5581

32413

(3020682) Albumin/Creatinine [Ratio] in Urine

5446

45865

0.75

62.44

3.6

4.2

9.61

9.60

mg/mmol

0.00

3425

28458

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8689

51833

1.29

59.65

4.8

53.29

92.32

ng/l

2.90

7137

42651

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

199

362

3.83

58.69

1.2

47.63

60.90

—

(1761868) Lipid panel - Serum or Plasma

2927

26789

0.71

57.04

3.4

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7153

41797

1.29

56.72

2.3

2.2

261.16

217.89

u/l

3.64

6713

39115

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1609

16389

0.65

55.70

1.2

1.3

16.64

15.51

u/ml

0.18

457

5381

(3019550) Sodium [Moles/volume] in Serum or Plasma

16273

105882

1.37

55.63

26.8

27.1

139.72

139.45

mmol/l

26.26

15893

103697

(3023103) Potassium [Moles/volume] in Serum or Plasma

16279

105952

1.37

55.26

26.9

27.3

4.00

4.01

mmol/l

3.62

15883

103640

(3013826) Glucose [Moles/volume] in Serum or Plasma

11755

73206

1.28

55.19

4.7

5.3

7.03

6.89

mmol/l

8.49

11246

70034

(3010813) Leukocytes [#/volume] in Blood

16332

106635

1.36

51.07

31.6

33.1

7.17

7.03

e9/l

4.95

15780

103269

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16306

106465

1.36

50.69

28.5

29.8

85.79

86.43

umol/l

1.36

15952

104807

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16325

106621

1.36

50.51

31.9

33.6

38.45

39.02

17.81

15974

104882

(3007461) Platelets [#/volume] in Blood

16324

106616

1.36

50.47

31.5

33.1

235.76

238.64

e9/l

6.23

15819

103739

(3035941) MCH [Entitic mass]

16324

106618

1.36

50.44

31.4

33.0

30.43

0.00

15982

104933

(3026361) Erythrocytes [#/volume] in Blood

16324

106622

1.36

50.38

31.5

33.1

4.25

4.32

e12/l

50.61

15756

103211

(3035350) Ketones [Presence] in Urine by Test strip

10057

61817

1.26

50.32

4.8

4.7

4.95

3.21

estimate

0.38

1922

14218

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16323

106621

1.35

50.29

31.5

33.0

92.07

92.04

0.38

15985

104936

(3000963) Hemoglobin [Mass/volume] in Blood

16324

106631

1.35

50.25

31.8

33.4

128.20

130.25

g/l

57.01

15979

104989

(3002179) Metamyelocytes/Leukocytes in Blood

1024

11222

0.61

48.79

3.3

4.0

0.65

0.70

0.32

288

3764

(3017181) Myelocytes/Leukocytes in Blood

1108

11856

0.63

47.54

3.5

4.0

1.01

0.94

0.22

321

3967

(3015736) pH of Urine

8209

49522

1.25

47.06

4.2

4.1

6.32

0.14

4282

26070

(3021440) Promyelocytes/Leukocytes in Blood

1051

11324

0.62

46.41

3.5

4.0

0.13

0.11

0.37

268

3466

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1809

17426

0.69

46.06

1.2

1.3

40.73

43.01

iu/ml

0.22

548

5247

(3025159) Blasts/Leukocytes in Blood

1055

11248

0.63

44.35

3.6

4.2

0.27

0.33

0.14

256

3248

(3037522) Nuclear Ab [Titer] in Serum

1328

13440

0.66

43.61

1.3

489.86

512.60

titre

0.20

280

3285

(3009261) Glucose [Presence] in Urine by Test strip

10042

62327

1.24

42.80

4.8

4.7

0.75

0.42

estimate

0.23

1792

13357

(3021601) Nitrite [Presence] in Urine by Test strip

9839

61041

1.23

41.55

4.8

4.7

0.00

estimate

0.02

1819

13668

(3011397) Hemoglobin [Presence] in Urine by Test strip

5047

29323

1.26

37.92

4.6

4.4

0.18

0.28

0.33

419

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4721

27238

1.26

37.59

4.5

4.6

195.07

425.98

ng/l

6.19

4290

24242

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7375

44780

1.22

36.56

5.1

4.9

1.22

0.87

estimate

0.24

1477

11086

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

923

9694

0.64

35.83

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

132

259

3.54

35.24

1.2

1.3

24.86

26.93

—

(3002256) Pathology report gross observation

1840

16826

0.73

33.16

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

266

803

2.31

32.76

2.2

2.3

—

(3003694) ABO and Rh group [Type] in Blood

3247

27398

0.78

32.16

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1054

4943

1.50

31.13

1.2

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2551

22100

0.77

31.07

4.0

4.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

925

9407

0.66

30.51

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

597

6644

0.61

29.78

2.0

1.98

1.37

g/l

2.05

503

5953

(3022145) Colonoscopy Study observation

1455

13399

0.73

27.01

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1879

16621

0.76

26.31

3.0

4.1

14.59

24.74

ug/l

1.45

1537

13990

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

920

9090

0.69

25.93

1.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

119

272

3.04

25.24

1.7

2.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

526

2201

1.67

25.23

1.1

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13545

88556

1.19

25.05

6.2

8.8

80.73

83.92

u/l

7.16

12576

83524

(3026493) Urate [Moles/volume] in Serum or Plasma

4005

32312

0.82

24.95

2.5

3.1

353.14

363.41

umol/l

6.58

3275

27295

(3005719) IgG [Mass/volume] in Serum or Plasma

835

8339

0.68

24.90

2.8

2.9

10.81

10.71

g/l

0.20

738

7633

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

117

272

2.99

24.14

1.7

2.1

—

(3032080) INR in Blood by Coagulation assay

10314

66193

1.16

22.71

20.2

21.1

1.41

1.38

inr

4.53

8893

56109

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

462

5117

0.62

22.53

2.6

4.3

142.96

95.40

u/ml

0.64

436

4924

(3021589) Normoblasts [#/volume] in Blood

6449

49552

0.85

22.37

11.5

13.5

0.00

e9/l

0.66

5169

40015

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1245

6393

1.37

22.35

1.5

1.6

1.65

1.64

0.25

1027

5118

(3018095) Leukocytes [#/volume] in Urine

7678

48292

1.16

21.55

4.6

4.5

149.70

135.79

e6/l

0.44

5602

35480

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3750

22194

1.21

21.51

3.5

2.65

2.59

e6/l

0.12

1926

11524

(3002582) Erythrocytes [#/volume] in Urine

7118

44532

1.17

21.34

3.8

109.96

100.55

e6/l

0.16

5551

34764

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

271

3359

0.55

20.47

2.0

3.1

178.58

1030.44

u/ml

2.84

237

3041

(3009445) Proteinase 3 Ab [Units/volume] in Serum

562

5839

0.66

20.45

1.5

42.79

16.74

iu/ml

0.94

124

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2381

13529

1.25

20.10

3.2

3.3

230.34

270.79

ng/l

4.20

2197

12523

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

307

3654

0.57

20.00

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

835

8022

0.71

19.93

1.3

1.5

—

(40768797) Stomach Pathology biopsy report

1989

16918

0.79

19.84

1.2

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12522

81961

1.16

19.65

4.2

4.9

15.15

15.68

mm/h

2.87

11340

75158

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4024

24176

1.19

19.31

3.4

1.45

1.33

e6/l

0.42

2233

13526

(36304419) Bacteria [Presence] in Urine

5808

35977

1.17

19.25

3.7

3.6

1290.45

213.36

estimate

0.40

247

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1733

9532

1.28

19.17

5.2

6.4

24.36

24.53

mmol/l

1.00

1670

9120

(3005322) IgE [Units/volume] in Serum or Plasma

490

5156

0.65

18.96

1.2

1.3

253.81

248.39

u/ml

0.06

435

4701

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

976

9051

0.73

18.66

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

200

690

2.02

17.93

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1164

0.31

17.40

1.8

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

144

2048

0.48

16.98

1.5

1.8

3.07

3.24

mmol/l

0.85

106

1515

(4034850) Laboratory test

678

3288

1.44

16.94

13.7

13.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

2195

0.50

16.93

3.8

3.9

201.74

1761.81

iu/ml

1.25

325

(3023420) DNA double strand Ab [Units/volume] in Serum

391

4212

0.64

16.90

1.7

1.6

7.99

8.20

iu/ml

0.04

986

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7401

55561

0.87

16.89

2.6

3.0

—

estimate

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2278

18792

0.82

16.81

2.9

4.0

246.32

250.00

u/l

0.44

2057

17719

(3029937) Albumin [Presence] in Urine by Test strip

5773

36030

1.15

16.75

5.1

4.8

0.00

estimate

2.22

1567

12183

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

454

4668

0.67

15.71

1.6

1.7

37.51

38.52

u/l

0.42

367

3944

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

252

2956

0.58

15.60

1.7

2.1

3.01

3.25

ratio

3.13

211

2419

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

373

3979

0.64

15.44

1.5

21.08

16.66

iu/ml

—

(40768793) Breast Pathology biopsy report

219

2657

0.57

15.41

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

790

7344

0.73

15.31

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2247

18400

0.82

15.24

1.4

1.5

2.75

2.73

g/l

0.11

1041

10051

(3013512) EKG study

6192

46817

0.88

15.17

4.2

4.5

0.87

0.72

0.82

124

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15650

104811

1.16

15.03

11.2

14.0

22.36

23.66

u/l

4.77

14881

100637

(3039000) Anion gap in Blood by calculation

597

2893

1.44

15.01

4.5

6.5

11.41

11.30

mmol/l

0.30

542

2599

(3018572) Chloride [Moles/volume] in Blood

597

2893

1.44

15.01

4.5

6.5

104.85

104.76

mmol/l

0.14

542

2600

(4024509) Urine culture

1179

6374

1.30

14.84

2.0

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2296

13417

1.21

14.51

2.5

5.70

6.43

ug/l

1.28

1779

11473

(3021879) Hepatitis B virus core Ab [Presence] in Serum

547

5344

0.70

14.39

1.2

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

493

4892

0.69

14.16

1.2

1.3

—

(40768443) Skin Pathology biopsy report

639

6063

0.72

14.12

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1689

14115

0.81

13.99

4.3

6.2

11.32

11.90

mmol/l

2.41

1560

13275

(3007566) Smooth muscle Ab [Titer] in Serum

221

2604

0.58

13.97

1.1

1.2

154.44

130.78

titre

0.13

206

(3006270) Folate [Moles/volume] in Blood

272

1124

1.68

13.89

1.2

312.12

307.11

nmol/l

0.14

215

832

(3047181) Lactate [Moles/volume] in Blood

809

4200

1.35

13.56

4.3

5.7

1.40

1.34

mmol/l

0.79

724

3739

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

262

1080

1.69

13.52

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

253

2857

0.61

13.50

1.3

3.00

4.54

u/ml

1.61

454

(3014051) Protein [Presence] in Urine by Test strip

4865

30371

1.14

13.44

3.5

3.6

0.12

0.08

0.47

196

1205

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2436

19597

0.84

13.43

3.7

5.3

1.02

1.04

mmol/l

4.42

2169

17941

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

254

2859

0.61

13.38

1.3

1.2

3.75

4.87

u/ml

0.27

309

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

11987

79097

1.13

13.28

26.9

27.3

14.02

14.07

3.47

11822

77973

(3004809) Band form neutrophils/Leukocytes in Blood

232

2660

0.60

13.19

3.8

3.6

1.63

1.56

0.09

184

2338

(3002030) Lymphocytes/Leukocytes in Blood

7452

55373

0.89

13.14

5.1

6.4

24.24

25.07

8.12

6917

51871

(3015171) Extractable nuclear Ab [Units/volume] in Serum

365

3774

0.66

13.04

1.3

1.2

0.51

1.03

u/ml

1.53

340

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

307

3290

0.64

13.03

2.0

2.1

3.68

3.66

g/l

0.09

286

3138

(3000494) Fungus identified in Specimen by Culture

1635

13614

0.82

13.02

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

274

3008

0.63

12.97

1.2

35.51

41.62

u/ml

0.12

153

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

624

5863

0.73

12.97

2.9

2.7

—

(3013115) Eosinophils [#/volume] in Blood

8164

60299

0.89

12.85

5.0

6.1

0.20

e9/l

0.46

6895

51164

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

180

2186

0.57

12.79

1.8

16.12

24.95

ug/l

5.73

175

2131

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1305

0.44

12.79

1.0

1.1

1.60

1.58

g/l

0.19

1159

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

269

2951

0.63

12.70

1.8

12.58

13.00

mg/l

0.34

237

2695

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

245

2734

0.62

12.47

1.2

1.3

157.14

270.43

titre

1.63

208

(3006315) Basophils [#/volume] in Blood

7977

58926

0.89

12.42

4.8

6.0

0.04

e9/l

1.88

6670

49239

(3001604) Monocytes [#/volume] in Blood

7937

58639

0.89

12.37

4.8

5.9

0.63

0.64

e9/l

0.52

6628

48918

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

160

1981

0.56

12.21

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

134

1747

0.53

12.20

1.2

—

(3022096) Basophils/Leukocytes in Blood

7386

54750

0.89

12.12

5.1

6.4

0.62

0.64

1.91

6749

50721

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

593

5547

0.73

11.99

2.3

3.2

338.04

2680.27

u/ml

2.78

474

4758

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

225

2527

0.61

11.79

1.3

1.2

1.82

5.44

u/ml

1.62

183

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

258

2805

0.63

11.74

2.2

2.1

212.09

214.78

0.17

235

2652

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1901

11141

1.20

11.55

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

280

2977

0.65

11.51

1.2

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12827

92138

0.89

11.50

4.0

4.7

1.20

1.24

mmol/l

14.76

11164

80914

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

133

1704

0.54

11.46

1.9

2.0

495.75

2179.62

u/ml

—

123

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

196

782

1.74

11.45

1.2

2.06

2.34

mmol/l

2.47

183

713

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

278

2956

0.65

11.43

1.9

89.73

88.70

0.37

260

2843

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6804

43702

1.12

11.43

5.5

6.7

5.54

4.69

ug/l

0.37

5909

38628

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

306

3186

0.66

11.37

1.6

1.5

1.15

1.17

g/l

0.57

286

3018

(3019198) Lymphocytes [#/volume] in Blood

8113

59701

0.90

11.37

4.9

6.1

1.74

1.84

e9/l

3.16

6914

51118

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1147

9776

0.80

11.36

2.7

3.0

58.08

56.44

ml/min/173m2

0.93

499

4583

(4281824) Cell count and differential, peritoneal fluid

1310

0.48

11.29

1.1

1.2

—

(3019069) Monocytes/Leukocytes in Blood

7423

54850

0.90

11.16

5.1

6.4

9.19

9.22

0.24

6788

50741

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

354

3569

0.68

11.16

2.1

2.6

1.70

1.87

mg/l

3.05

283

3124

(3006504) Eosinophils/Leukocytes in Blood

7404

54705

0.90

11.09

5.0

6.3

2.82

2.80

0.27

6773

50633

(3022621) pH of Urine by Test strip

1657

9632

1.21

10.97

3.5

3.3

6.13

6.04

3.58

1303

6884

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7700

49896

1.11

10.83

2.9

3.2

137.44

159.53

ug/l

12.78

6830

44989

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

302

3112

0.67

10.68

1.6

1.5

0.23

g/l

0.53

282

2933

(3042631) Mycobacterium sp identified in Specimen

206

2299

0.62

10.56

2.4

2.8

—

(3018010) Neutrophils/Leukocytes in Blood

7331

54103

0.90

10.55

5.0

6.2

60.18

59.41

6.01

6821

51143

(21494755) Public health laboratory ask at order entry panel

1114

0.46

10.45

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

1283

0.49

10.43

1.1

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

5525

41361

0.89

10.31

2.4

2.7

—

(3023419) Bacteria identified in Sputum by Culture

173

2000

0.59

10.28

2.3

2.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13422

95973

0.90

10.25

4.6

5.6

1.46

1.45

mmol/l

1.74

11877

85550

(3030467) Casts [#/volume] in Urine by Automated count

6054

38809

1.11

10.24

3.7

0.56

0.50

e6/l

1.01

4576

29481

(3003434) Protein [Mass/volume] in Pleural fluid

291

2989

0.67

10.15

1.4

1.5

30.76

31.18

g/l

0.25

260

2691

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

476

1.90

10.07

1.1

39.67

47.70

mg/l

1.17

108

406

(3013650) Neutrophils [#/volume] in Blood by Automated count

9065

66074

0.91

9.99

6.6

9.3

4.62

4.43

e9/l

8.57

7686

56417

(3045142) Bone marrow Pathology biopsy report

139

1686

0.57

9.94

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

616

3221

1.33

9.94

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

616

3221

1.33

9.94

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

131

1609

0.56

9.82

1.5

1.6

0.69

0.88

g/l

1.55

103

1227

(3044889) 12 lead EKG panel

11512

76378

1.10

9.73

5.1

0.60

555.74

0.50

182

(3017732) Neutrophils [#/volume] in Blood

1741

14046

0.84

9.73

3.0

3.2

5.45

4.98

e9/l

0.66

1394

11454

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1928

15414

0.85

9.64

5.0

5.6

34.88

34.01

2.56

1162

9593

(3052592) Norovirus Ag [Presence] in Stool

284

2.15

9.62

1.2

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

313

2.08

9.50

1.1

1.2

0.52

0.51

ratio

0.04

187

(40768441) Liver Pathology biopsy report

769

0.39

9.40

1.0

1.2

—

(40758558) Short blood count panel - Blood

5388

34451

1.11

9.37

5.6

6.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

268

2749

0.67

9.32

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1135

9481

0.82

9.27

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

264

2705

0.67

9.14

1.3

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

446

4171

0.73

9.08

1.5

1.7

—

(40768806) Pleura Pathology biopsy report

207

2226

0.64

9.07

1.5

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5449

34918

1.11

9.02

4.9

5.4

22.39

22.58

0.40

2860

19930

(3017354) Segmented neutrophils/Leukocytes in Blood

151

1742

0.60

8.96

2.8

3.6

59.41

58.60

0.16

105

1468

(3020191) Ethanol [Moles/volume] in Serum or Plasma

147

583

1.75

8.89

1.2

0.77

0.94

promille

0.83

121

441

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

244

2520

0.67

8.81

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

121

1468

0.57

8.73

1.2

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

101

1286

0.54

8.65

1.1

1.2

51.71

35.38

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

943

0.47

8.61

2.4

1.9

914.30

1049.32

e6/l

0.92

856

(3000850) Epithelial cells [#/volume] in Urine

4961

31702

1.11

8.58

2.9

5.75

5.11

e6/l

2.84

4536

28821

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4164

31400

0.90

8.53

2.3

2.6

—

(3042936) Bacteria identified in Isolate by Culture

2455

19115

0.87

8.51

1.9

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

261

2635

0.68

8.40

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

150

1677

0.62

7.88

1.4

1.3

0.12

0.31

nmol/l

—

127

(3014271) Vancomycin [Susceptibility]

224

1021

1.52

7.87

3.3

3.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

186

1976

0.65

7.77

1.3

1.2

59.42

46.13

u/ml

0.49

211

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

555

4919

0.77

7.73

1.1

1.2

72.00

121.31

u/ml

3.56

175

1571

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3044

23248

0.89

7.70

2.2

2.9

0.81

mmol/l

0.30

2744

21518

(3036782) Glucose [Moles/volume] in Pleural fluid

182

1938

0.65

7.69

1.3

1.4

6.31

6.39

mmol/l

0.15

163

1823

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

322

3077

0.72

7.60

1.5

32.50

4.89

iu/ml

0.98

101

695

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

950

5427

1.22

7.55

1.9

2.1

834.70

580.92

ug/l

0.56

896

5162

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

115

1356

0.58

7.52

2.5

4.0

45.19

70.99

u/ml

0.87

108

1325

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

115

447

1.78

7.52

1.1

279.18

320.56

mg/l

1.28

394

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

3013

0.72

7.48

1.3

1.4

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

137

2.48

7.48

1.2

1.3

25.29

51.05

2.20

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

148

1632

0.62

7.36

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

849

7130

0.82

7.34

2.1

2.2

11.09

11.27

nmol/l

0.23

692

6036

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

351

1.88

7.30

3.0

2.8

27.73

29.62

umol/l

0.95

263

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

681

5849

0.80

7.29

2.1

2.6

0.38

0.35

iu/ml

1.00

376

3251

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

150

1641

0.63

7.21

1.4

1.3

0.66

2.78

nmol/l

1.00

140

1567

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

665

0.43

7.20

1.6

1.3

0.93

1.52

u/ml

0.33

409

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1118

0.55

7.16

1.2

84.20

76.62

u/ml

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.61

7.14

1.2

1.4

11.93

14.09

0.16

(3023199) Leukocytes [#/volume] in Pleural fluid

264

2574

0.71

7.06

1.4

1.5

3291.70

2514.47

e6/l

0.32

191

1816

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

220

2214

0.68

7.04

1.3

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

250

2.02

6.98

1.4

0.23

0.30

mmol/l

0.55

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13638

96848

0.92

6.89

4.8

5.7

4.30

4.33

mmol/l

4.06

12152

87144

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

942

0.53

6.86

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2489

15472

1.13

6.86

9.5

8.8

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.23

6.84

1.3

1.4

50.80

43.29

0.27

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.81

6.77

1.3

1.27

1.78

0.15

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

734

0.47

6.77

1.2

1.1

0.30

1.00

u/ml

2.78

421

(3008898) HLA-B27 [Presence]

152

1630

0.64

6.71

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

769

0.48

6.70

2.1

1.9

36.50

37.03

0.11

747

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

125

1399

0.62

6.67

1.3

153.94

160.59

au/ml

0.34

414

(3048689) Calprotectin [Mass/mass] in Stool

1436

11416

0.86

6.63

1.8

2.0

179.31

168.38

ug/g

0.36

1063

8801

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

125

1396

0.62

6.62

1.1

1.2

—

93.59

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

134

1469

0.63

6.55

1.3

0.19

0.20

nmol/l

0.67

110

1209

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

183

1877

0.67

6.51

3.2

3.6

29.09

46.13

u/ml

2.29

176

1823

(40768800) Prostate Pathology biopsy report

340

3140

0.74

6.48

1.2

—

(3035715) Granulocytes [#/volume] in Blood

209

2085

0.69

6.42

2.4

3.2

4.81

4.44

e9/l

0.97

209

2079

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

423

1.74

6.41

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

495

0.38

6.40

1.2

1.3

1.57

1.55

g/l

0.13

495

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

756

0.49

6.40

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

272

2588

0.72

6.32

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1007

0.56

6.32

1.4

2.92

2.90

g/l

0.03

712

(3027135) IgG subclass 1 [Mass/volume] in Serum

1006

0.56

6.30

1.4

6.82

7.17

g/l

0.38

707

(3024139) IgG subclass 3 [Mass/volume] in Serum

1006

0.56

6.30

1.4

0.41

0.45

g/l

0.48

709

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

898

0.54

6.29

3.4

3.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

162

1689

0.66

6.27

1.1

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

202

2015

0.69

6.21

1.3

428.97

430.23

u/l

0.00

186

1912

(3041096) Erythrocytes [Presence] in Urine by Automated

4724

30523

1.09

6.18

4.3

0.88

0.37

estimate

0.75

1373

10593

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

135

1457

0.64

6.17

1.1

1.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

3112

19709

1.11

6.15

2.0

2.4

1.72

1.79

3.39

2610

17304

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

102

410

1.73

6.04

2.5

2.1

61.56

51.42

umol/l

2.20

336

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

166

1707

0.67

6.02

1.1

—

0.66

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

239

2302

0.71

6.02

1.4

1.5

51740.94

64514.30

e6/l

0.37

142

1301

(3003129) Base excess in Capillary blood by calculation

170

1733

0.68

5.90

1.9

2.5

0.64

0.46

mmol/l

0.21

150

1672

(3037692) Legionella sp identified in Specimen by Organism specific culture

481

0.40

5.76

1.4

1.2

—

(4062490) Immunoglobulin typing, IgG

988

0.58

5.75

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6052

39618

1.08

5.74

2.3

2.7

175.85

62.06

u/l

0.57

5540

36341

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

118

1289

0.63

5.74

1.1

1.2

244.61

285.96

u/ml

0.98

743

(3020630) Protein [Mass/volume] in Serum or Plasma

1847

14286

0.88

5.69

2.2

2.6

65.48

65.69

g/l

0.54

1571

12836

(3024666) Lithium [Moles/volume] in Serum or Plasma

184

2.07

5.67

14.7

12.5

0.67

0.66

mmol/l

0.14

166

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

1242

0.63

5.65

1.4

1.3

11.57

13.02

u/l

0.48

977

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

167

1692

0.68

5.64

3.3

3.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1170

9326

0.86

5.61

5.2

7.8

24.15

24.30

mmol/l

0.77

1118

9024

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

666

0.50

5.59

1.1

—

(3045788) Cell count panel - Pleural fluid

212

2052

0.71

5.54

1.4

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

107

1184

0.62

5.52

1.5

1.7

4.34

4.73

mg/l

0.56

1121

(3038026) Centromere Ab [Units/volume] in Serum

959

0.58

5.51

1.1

1.2

50.12

59.41

u/ml

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2326

14589

1.12

5.48

4.9

7.2

119.71

118.82

g/l

1.37

2271

14248

(3034860) Kappa light chains.free [Mass/volume] in Serum

771

6343

0.83

5.45

2.7

3.2

57.92

75.48

mg/l

0.85

644

5359

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

602

0.48

5.41

2.1

2.2

12.32

30.23

iu/ml

—

116

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

354

0.33

5.36

1.2

1.3

0.54

0.60

ratio

0.49

119

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

472

4072

0.80

5.36

1.7

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1080

0.61

5.34

1.1

—

(40765096) Chromosome analysis panel by Banding

441

0.41

5.23

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

721

0.54

5.18

1.1

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

721

0.54

5.18

1.1

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

721

0.54

5.18

1.1

1.6

—

(3022313) Gas panel - Capillary blood

850

6901

0.85

5.17

3.1

4.1

—

(1002224) Polysomnography panel

208

1993

0.72

5.14

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

431

1.64

5.10

1.4

1.5

99.56

87.77

umol/l

0.29

246

(21494434) Karyotype in Bone marrow

137

1412

0.67

5.10

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

153

1542

0.68

5.07

1.1

1.2

2.50

4.53

u/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

775

6328

0.84

5.05

2.6

3.2

43.46

50.27

mg/l

0.69

652

5343

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

222

1.90

5.04

1.5

1.9

1.20

1.19

mmol/l

0.43

214

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

102

2.38

5.02

1.0

—

(3011985) Renin [Units/volume] in Plasma

161

1602

0.69

4.98

1.2

1.4

31.39

61.77

mu/l

3.25

132

1418

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

162

1609

0.69

4.96

1.2

1.3

21.70

12.93

u/l

1.53

144

1476

(3024354) Oxygen [Partial pressure] in Venous blood

2119

13298

1.12

4.94

2.5

3.1

4.15

4.36

kpa

6.17

2042

12929

(3018405) Lactate [Moles/volume] in Arterial blood

850

5013

1.18

4.92

3.2

3.7

1.43

1.42

mmol/l

0.09

833

4899

(3020876) Protein [Mass/time] in 24 hour Urine

214

2025

0.73

4.91

2.0

2.3

0.90

1.06

g/24h

0.44

1160

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

1184

0.65

4.91

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

1184

0.65

4.91

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

1184

0.65

4.91

1.2

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9047

60345

1.07

4.90

3.0

3.3

49.22

58.89

u/l

16.91

8107

54542

(3028717) Thiamine [Mass/volume] in Blood

112

2.29

4.89

1.1

64.76

62.83

ug/l

0.21

112

(21494890) Protein electrophoresis panel - 24 hour Urine

181

1757

0.71

4.87

1.8

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

523

0.48

4.86

1.6

1.9

5287.91

3655.62

e6/l

0.13

347

(3010726) Horse dander IgE Ab [Units/volume] in Serum

446

0.43

4.85

1.1

0.16

0.34

u/ml

0.82

252

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

420

3627

0.80

4.85

1.7

1.6

36.24

31.49

u/ml

0.31

538

(3015235) Bicarbonate [Moles/volume] in Capillary blood

684

5624

0.84

4.84

2.4

3.1

24.86

24.90

mmol/l

0.09

664

5529

(3025130) Human papilloma virus identified in Specimen

651

0.53

4.83

1.9

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

135

1376

0.68

4.78

1.4

1.3

—

nmol/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

528

2986

1.23

4.77

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

719

0.56

4.75

1.1

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

149

1488

0.69

4.73

1.1

1.3

232.12

273.27

pmol/l

1.74

115

1222

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

106

1131

0.65

4.71

1.2

3.33

5.02

u/ml

0.44

407

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

627

0.53

4.70

1.0

296.12

292.73

mg/l

0.11

551

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

279

2523

0.76

4.70

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

423

2339

1.26

4.69

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

528

2995

1.23

4.65

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

418

0.43

4.63

1.0

1.8

267366.80

35279.34

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

1473

0.69

4.62

1.1

1.2

60.46

60.45

u/l

0.00

125

1286

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

456

0.45

4.62

1.6

1.7

10586.06

17065.93

e6/l

0.37

245

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

121

1250

0.67

4.60

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

577

0.51

4.60

1.0

2.38

1.52

u/ml

0.22

268

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

176

0.24

4.58

1.3

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

566

0.51

4.56

1.0

1.1

0.54

0.86

u/ml

0.48

252

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1320

10277

0.88

4.54

3.0

3.9

5.19

5.15

kpa

0.60

1197

9757

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

601

0.53

4.53

2.1

1.8

462.49

499.84

e6/l

0.23

497

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

520

2960

1.22

4.45

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

207

1047

1.37

4.40

1.2

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

210

1067

1.37

4.35

1.2

1.3

—

(3009343) pH of Capillary blood

1288

10012

0.88

4.33

3.0

3.9

7.42

0.16

1073

8434

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

204

0.30

4.33

10.4

13.2

5.27

5.21

mmol/l

—

204

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

4.30

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

276

1.73

4.28

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

492

2797

1.22

4.28

4.1

3.9

31.39

29.98

mg/l

0.34

376

2024

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

365

0.42

4.27

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

365

0.42

4.27

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

365

0.42

4.27

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

365

0.42

4.27

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

1572

0.72

4.27

4.5

3.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

513

1.53

4.26

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

137

1360

0.69

4.25

1.1

—

(3019225) pH of Specimen

2216

14052

1.10

4.24

4.0

4.6

7.35

7.37

1.84

1489

9869

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

961

0.64

4.23

1.1

115.15

114.51

0.06

831

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

524

0.51

4.23

1.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

524

0.51

4.23

1.1

1.7

—

(3026782) Osmolality of Urine

4257

27777

1.08

4.18

3.1

3.3

539.23

525.13

mosm/kgh2o

4.72

3736

24336

(4268621) Lupus anticoagulant assay

759

0.60

4.12

2.1

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

698

0.58

4.12

2.2

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14555

98887

1.07

4.12

5.4

6.2

6.18

6.13

mmol/l

3.44

12830

87553

(3035880) pH of Pleural fluid

108

1113

0.67

4.11

1.2

1.3

7.42

7.41

0.22

798

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

600

0.55

4.11

2.1

2.0

207.33

237.16

e6/l

0.76

534

(3012565) Volume of 24 hour Urine

617

0.56

4.09

2.2

1652.06

1771.94

0.34

521

(3014111) Lactate [Moles/volume] in Serum or Plasma

2128

13493

1.10

4.08

3.9

6.3

1.45

1.37

mmol/l

2.53

2069

13167

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

175

1654

0.73

4.07

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1071

6530

1.14

4.05

4.1

4.9

0.90

0.85

3.61

1021

6197

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

254

1345

1.31

4.02

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

762

0.61

4.01

1.1

1.2

93.80

91.83

0.30

696

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

13736

96872

0.94

4.00

21.3

22.3

67.89

68.85

ml/min/173m2

7.62

12900

91095

(3040151) Glucose [Moles/volume] in Capillary blood

336

1847

1.26

3.99

7.2

11.0

8.41

7.35

mmol/l

1.64

274

1528

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

424

3571

0.82

3.94

1.3

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

118

551

1.48

3.93

1.2

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

351

0.43

3.91

1.0

1.1

0.12

1.02

u/ml

—

164

(3036489) Thrombin time

487

4042

0.83

3.90

1.6

1.8

21.39

21.73

0.33

436

3690

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

708

5691

0.86

3.88

2.6

3.1

4.41

6.90

ratio

0.51

453

3386

(3004775) Volume in Urine collected for unspecified duration

115

1157

0.69

3.88

2.3

2.2

624.19

652.03

0.33

730

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

694

0.60

3.87

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1024

0.67

3.87

1.2

1.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

588

0.56

3.85

1.1

1.4

19.13

18.75

0.04

523

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

173

1.88

3.84

3.0

0.51

0.49

u/field

0.05

173

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

1072

0.68

3.84

1.1

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1155

7106

1.13

3.82

4.0

4.7

1.63

1.53

1.86

1106

6766

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

786

0.62

3.82

1.1

33.22

27.56

u/l

0.35

668

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

299

2603

0.79

3.80

1.3

35.18

38.33

u/l

0.21

262

2220

(3029075) Extractable nuclear Ab panel - Serum

559

0.56

3.80

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

791

0.63

3.75

1.1

96.34

86.43

u/l

0.51

675

(3028626) Oxygen [Partial pressure] in Capillary blood

490

4048

0.83

3.74

2.4

3.1

7.54

7.77

kpa

2.41

475

3951

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

529

0.55

3.73

1.2

1.7

—

(4146454) Self-monitoring of blood glucose

184

1701

0.75

3.73

2.6

2.7

—

(40757373) Influenza virus identified in Isolate

257

1.70

3.70

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

108

1088

0.69

3.69

1.2

3.91

4.78

u/ml

0.37

491

(44813793) Dust mix specific IgE antibody measurement

554

0.56

3.69

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

172

1.85

3.61

1.9

2.5

138.75

130.38

nmol/l

0.22

150

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.45

3.59

1.1

14.80

26.84

nmol/l

—

(40768446) Kidney Pathology biopsy report

319

0.43

3.58

1.1

1.5

—

(3000012) Reticulocyte production index

313

2690

0.80

3.57

1.9

2.2

0.83

0.89

1.48

210

1891

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

566

0.57

3.57

2.3

2.5

41.35

36.12

1.09

338

(3006922) Hepatitis E virus Ab [Presence] in Serum

601

0.59

3.57

1.1

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

165

1538

0.74

3.56

1.1

1.2

—

39.21

u/ml

—

(3047189) Immunofixation for 24 hour Urine

780

0.64

3.55

1.2

1.6

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

651

0.60

3.53

1.3

1.4

2.78

2.33

0.20

545

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

325

0.45

3.49

1.1

1.4

124.99

147.75

pmol/l

0.41

325

(3016750) Collection duration of Urine

802

0.65

3.49

2.2

2.1

484.91

500.37

min

0.52

556

(3005532) Lymphocytes/Leukocytes in Pleural fluid

742

0.63

3.47

1.2

1.4

62.22

66.73

0.47

604

(3008295) Osmolality of Serum or Plasma

277

1516

1.27

3.47

1.3

276.09

273.95

mosm/kgh2o

0.63

197

1094

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

159

1484

0.74

3.47

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1827

11596

1.10

3.46

2.8

3.7

88.06

98.63

ng/l

6.37

1502

9596

(3027456) Digoxin [Moles/volume] in Serum or Plasma

761

4594

1.15

3.38

3.8

3.4

0.77

0.82

nmol/l

3.68

626

3716

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

129

1237

0.72

3.36

1.1

60.86

423.17

iu/ml

0.83

205

(4195642) Thrombophilia screening test

959

0.68

3.33

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

475

1.47

3.32

2.0

2.4

4.83

4.97

kpa

0.64

101

475

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

475

1.47

3.32

2.0

2.4

9.58

10.02

kpa

1.03

101

475

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1845

11747

1.10

3.28

2.8

2.6

0.57

0.50

e6/l

0.65

1786

11378

(3026692) Albumin [Mass/volume] in Peritoneal fluid

382

0.51

3.28

1.3

1.4

13.51

15.00

g/l

0.40

296

(3024932) HLA-DR beta [Type]

155

0.31

3.27

1.3

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

228

0.36

3.27

1.8

2.7

648.75

1006.66

u/l

0.23

211

(3003181) Sodium [Moles/volume] in Urine

533

3141

1.18

3.25

1.3

1.4

62.60

60.19

mmol/l

0.80

435

2538

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

153

1417

0.75

3.20

1.3

1.4

14.08

13.58

u/l

0.46

144

1358

(3007916) DNA double strand Ab [Titer] in Serum

130

0.27

3.19

1.2

1.3

—

87.40

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

369

0.51

3.19

1.0

1.1

0.08

1.63

u/ml

3.24

188

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

908

0.68

3.17

1.2

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

175

1.78

3.17

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

574

3412

1.17

3.16

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

518

4190

0.85

3.15

2.7

3.3

—

514.14

—

(3021901) Oxygen saturation in Capillary blood

437

3585

0.84

3.15

2.5

3.1

87.91

88.73

1.60

422

3489

(3024471) HLA-A [Type]

162

0.34

3.13

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

474

2776

1.19

3.12

1.5

2.1

25.21

32.72

umol/l

12.60

391

2382

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

250

2164

0.80

3.10

1.2

1.4

22.38

14.29

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

256

2206

0.80

3.06

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

432

3537

0.84

3.05

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

470

0.57

3.03

1.2

1.7

89.34

99.08

1.22

447

(3017569) Oxygen content in Arterial blood

104

1013

0.71

3.02

2.5

2.1

16.14

15.59

1.16

104

1013

(3020911) Cortisol [Moles/time] in 24 hour Urine

315

0.48

3.00

1.3

1.4

64.77

281.74

nmol/24h

1.52

315

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

314

0.48

2.98

2.6

2.2

3.77

632.79

ug/l

1.04

314

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

343

1959

1.22

2.98

1.1

7.41

13.33

eliau/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

879

0.69

2.96

1.2

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

255

0.43

2.93

1.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

125

1175

0.73

2.92

1.7

1.8

172.30

187.31

pmol/l

1.32

108

1069

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3407

24874

0.94

2.92

1.6

1.7

1.73

1.61

mg/l

0.89

2669

19852

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

860

0.69

2.92

1.3

1.2

8.10

8.04

mmol/l

0.06

665

(3044007) Cell count panel - Peritoneal fluid

437

0.57

2.89

1.8

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

201

1768

0.78

2.89

1.5

1.7

6.52

4.79

mg/l

0.66

153

1370

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

301

0.48

2.89

1.0

0.46

0.18

u/ml

—

138

(3039443) Prostate specific Ag panel - Serum or Plasma

102

988

0.71

2.89

1.5

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4736

34216

0.94

2.88

2.7

3.2

34.72

36.46

u/l

0.53

4385

31825

(3002079) Sodium [Moles/time] in 24 hour Urine

436

0.57

2.87

1.1

1.2

148.08

156.71

mmol/24h

0.20

436

(3010421) pH of Blood

604

4790

0.87

2.86

3.1

3.8

7.41

0.39

588

4713

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

103

993

0.72

2.84

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

222

0.40

2.83

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

836

0.69

2.79

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

581

1.38

2.77

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

234

2010

0.80

2.75

1.6

1.8

4.54

4.33

mmol/24h

0.46

184

1687

(3033099) Centromere Ab [Titer] in Serum

267

0.47

2.75

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.01

2.74

12.0

12.9

0.34

0.23

0.77

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

163

0.38

2.74

1.1

1.0

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

473

0.60

2.73

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

823

0.70

2.71

1.6

1.5

4.42

7.28

u/l

1.28

645

(3003396) Base excess in Arterial blood by calculation

2755

17967

1.07

2.71

4.5

6.5

1.13

1.00

mmol/l

0.90

2162

14736

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

821

0.70

2.68

1.1

1.2

272.86

137.99

titre

0.57

149

(3019977) pH of Arterial blood

2768

18070

1.07

2.64

4.6

6.6

7.42

1.01

1671

10015

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

825

0.70

2.62

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

825

0.70

2.62

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

132

1206

0.76

2.59

1.3

1.2

66.69

52.21

u/ml

—

(1616796) Gas panel - Central venous blood

446

3586

0.86

2.58

3.1

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

907

5648

1.12

2.56

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1292

8194

1.10

2.55

2.2

2.6

1.13

0.02

1285

8158

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1168

8846

0.91

2.55

2.9

3.8

1.90

2.07

mmol/l

0.76

829

6563

(3004451) EKG impression Narrative

110

1027

0.74

2.52

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

142

1279

0.77

2.52

1.1

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

427

0.60

2.50

2.7

2.3

0.63

0.62

mmol/l

0.56

427

(40758292) HTLV I+II Ab panel - Serum

145

0.38

2.48

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

970

6075

1.11

2.47

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

194

1678

0.80

2.47

1.4

1.5

71.31

62.81

2.97

124

1035

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

1343

0.78

2.44

1.1

1.5

—

(3016502) Oxygen saturation in Arterial blood

2474

16138

1.07

2.43

4.6

6.7

95.16

95.06

0.26

2374

15541

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

147

1311

0.77

2.43

1.0

—

(3028433) Virus identified in Specimen by Culture

380

0.58

2.43

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

379

0.58

2.41

1.3

45.39

37.28

u/l

0.40

310

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

207

1770

0.81

2.39

1.2

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

242

2035

0.82

2.38

1.3

0.83

0.85

nmol/l

0.08

200

1676

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2761

18089

1.07

2.37

4.6

6.6

4.97

5.07

kpa

5.50

2641

17288

(3002032) Base excess in Venous blood by calculation

2373

15470

1.07

2.37

2.8

3.7

1.94

1.83

mmol/l

0.74

2074

13449

(3027801) Oxygen [Partial pressure] in Arterial blood

2759

18077

1.07

2.37

4.6

6.6

11.70

11.75

kpa

0.18

2639

17266

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1278

8135

1.09

2.35

2.2

2.6

0.64

0.63

0.87

1272

8106

(3022689) Creatine [Moles/volume] in Urine

367

0.58

2.34

1.2

1.4

6.98

6.72

mmol/l

0.13

367

(3001019) Free T4 and TSH panel - Serum or Plasma

124

1124

0.76

2.33

1.6

1.7

—

(3034426) Prothrombin time (PT)

231

0.48

2.31

1.1

1.2

27.06

28.51

0.86

231

(3012544) pH of Venous blood

2460

16076

1.07

2.29

2.8

3.7

7.38

0.53

1370

9618

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1343

8579

1.09

2.29

2.5

3.7

24.21

24.19

mmol/l

0.07

1308

8447

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

425

1.40

2.29

1.1

27.89

430.35

ng/l

2.22

126

(3014007) Fractional oxyhemoglobin in Arterial blood

1325

9918

0.92

2.26

5.5

8.1

93.20

93.65

1.39

1320

9881

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

508

0.65

2.26

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

336

0.58

2.24

1.3

28.58

44.71

g/l

0.50

283

(3024522) Salmonella sp identified in Specimen by Organism specific culture

211

1784

0.82

2.21

1.2

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

117

0.35

2.20

1.2

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

766

0.72

2.20

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

790

0.73

2.20

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

488

0.65

2.20

1.1

83.86

82.40

—

(3038515) Glucose [Moles/volume] in Venous blood

474

3743

0.87

2.19

3.6

3.8

8.14

7.68

mmol/l

2.19

462

3654

(3045424) Erythrocytes [Presence] in Urine

837

6389

0.90

2.18

2.0

2.2

0.00

0.17

estimate

0.57

198

1585

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

337

1.44

2.17

1.4

17.38

16.78

pmol/l

0.36

270

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

196

0.46

2.14

1.0

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

649

0.70

2.14

1.3

1.5

3.31

3.43

0.04

143

(3000093) Morphology [Interpretation] in Blood Narrative

178

1525

0.81

2.13

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

116

610

1.32

2.12

1.2

1.3

1.20

1.18

nmol/l

0.06

441

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1253

9371

0.92

2.11

4.6

6.7

24.77

24.79

mmol/l

0.07

1238

9282

(1761482) Bacteria [#/volume] in Urine by Culture

546

4259

0.88

2.10

4.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

372

0.61

2.08

1.3

1.4

0.14

nmol/l

0.04

243

(44816559) Phosphatidylethanol [Mass/volume] in Blood

444

2684

1.15

2.08

1.4

0.30

0.28

mg/l

0.28

183

1045

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

869

0.75

2.08

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

422

0.64

2.07

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

198

1670

0.82

2.06

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

327

0.59

2.05

1.4

1.5

18.78

10.56

—

163

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

850

0.75

2.03

1.1

1.2

82.53

99.28

u/l

0.97

720

(40759836) Histone Ab [Presence] in Serum by Immunoblot

746

0.73

2.02

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

171

0.44

1.98

3.3

1.6

59.64

59.40

pmol/l

0.00

133

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

417

0.65

1.97

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

226

0.52

1.97

1.9

1.7

2.43

2.24

ug/l

0.09

131

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

244

0.54

1.96

1.1

1.3

113.75

113.33

0.03

210

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

725

0.73

1.95

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

724

0.73

1.93

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

163

908

1.24

1.93

2.0

1.8

8.50

8.14

mmol/l

0.43

163

908

(3008037) Lactate [Moles/volume] in Venous blood

562

4349

0.89

1.93

3.4

3.6

1.73

1.63

mmol/l

1.38

548

4247

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

101

0.34

1.92

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

372

0.63

1.92

2.6

1.8

185.86

183.68

0.03

340

(40761536) Microorganisms panel - Urine sediment

1302

9678

0.93

1.91

4.9

4.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2423

15924

1.06

1.91

2.8

3.7

5.85

5.81

kpa

0.84

2347

15529

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.90

0.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

545

0.70

1.90

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2885

20896

0.95

1.90

1.2

1.3

1.73

1.67

u/ml

0.08

610

4858

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

943

7100

0.91

1.89

2.0

2.3

3.78

3.73

g/l

0.39

793

6339

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

221

1826

0.84

1.88

1.3

1.4

—

(44806420) Estimation of glomerular filtration rate

704

0.74

1.87

2.8

2.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

204

1696

0.83

1.86

1.2

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

248

2026

0.85

1.85

5.0

6.0

12.82

12.73

mg/l

0.10

217

1848

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

946

7114

0.92

1.85

1.9

2.3

4.10

4.17

g/l

2.11

796

6355

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

947

7119

0.92

1.84

2.0

2.3

7.61

7.51

g/l

1.01

796

6352

(3016038) Potassium [Moles/volume] in Urine

191

1090

1.21

1.82

1.1

35.52

34.93

mmol/l

0.12

152

926

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

205

1698

0.83

1.80

1.2

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

239

1395

1.19

1.80

1.9

1.6

30.53

25.80

u/ml

0.74

274

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

695

5293

0.91

1.79

3.3

4.3

25.01

24.90

mmol/l

0.40

594

4782

(3003577) Lead [Moles/volume] in Blood

2.25

1.79

1.2

1.1

0.12

0.09

umol/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.35

1.79

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

622

3885

1.11

1.77

2.0

2.3

126.84

125.52

g/l

0.66

511

2966

(3037121) Protein [Mass/volume] in Urine

642

4904

0.90

1.76

2.5

3.0

1004.75

654.46

mg/l

0.21

218

2085

(3005988) Vibrio sp identified in Specimen by Organism specific culture

206

1701

0.84

1.76

1.2

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

208

0.53

1.75

1.1

1.2

—

1484.44

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

162

0.47

1.75

2.0

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

829

0.77

1.75

1.1

1.2

28.66

30.57

u/l

0.13

692

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

711

0.75

1.75

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

224

1304

1.19

1.74

2.4

2.2

1.98

1.83

u/field

0.23

133

677

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

221

1811

0.84

1.74

1.2

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

867

0.77

1.73

1.2

220.23

178.65

miu/ml

0.22

166

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

386

0.66

1.71

1.1

1.06

1.09

ratio

0.91

295

(3038071) Oxygen [Partial pressure] in Mixed venous blood

250

0.58

1.70

6.4

8.1

7.05

5.57

kpa

0.62

250

(3003329) Lymphocytes/Leukocytes in Synovial fluid

150

1270

0.82

1.68

1.5

18.85

26.58

3.30

777

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

125

1079

0.80

1.68

1.1

87.67

27.15

au/ml

—

(3000285) Sodium [Moles/volume] in Blood

320

1.39

1.68

1.4

1.3

138.54

138.19

mmol/l

0.28

269

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

240

0.58

1.67

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

698

0.75

1.67

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

506

0.71

1.66

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

562

0.73

1.66

6.0

6.3

29.07

112.44

ug/l

0.83

354

(3004119) Hemoglobin [Mass/volume] in Venous blood

1495

9726

1.07

1.66

2.6

3.2

127.84

125.88

g/l

3.08

1453

9430

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.36

1.65

2.6

2.3

—

94.91

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

399

0.68

1.64

1.4

30.71

29.44

umol/l

0.37

372

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

600

0.74

1.63

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.84

1.62

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

749

0.77

1.62

4.8

5.2

55.45

111.47

u/ml

0.59

233

(4015189) Microbial culture of sputum

414

0.68

1.62

2.8

2.2

—

(3026726) Creatinine [Moles/volume] in Specimen

123

0.45

1.62

2.5

2.4

158.00

383.04

umol/l

—

115

(3027035) Albumin [Mass/time] in 24 hour Urine

123

0.45

1.62

1.5

1.3

—

803.99

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

296

1.38

1.54

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

140

1179

0.82

1.52

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

687

0.76

1.52

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

632

0.75

1.52

1.3

1084.04

189.05

ug/l

0.89

340

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14218

99377

0.96

1.52

5.7

6.6

2.40

2.44

mmol/l

4.92

12701

89145

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

293

1.37

1.47

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

296

0.65

1.42

6.8

8.1

5.71

5.96

kpa

1.07

250

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.40

1.40

1.6

1.3

—

(3024263) Appearance of Synovial fluid

114

637

1.24

1.40

1.4

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1132

8344

0.93

1.39

1.5

1.7

1.61

1.57

g/l

0.68

920

7125

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

1.38

0.0

1.0

—

0.03

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.38

0.0

7.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

1.38

0.0

1.0

—

0.05

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

232

1.40

1.38

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

668

0.78

1.37

4.6

3.2

1.38

1.24

0.24

668

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

318

0.67

1.37

1.2

—

2093931.13

—

(3041354) Potassium [Moles/volume] in Venous blood

281

2212

0.88

1.37

2.6

2.5

4.15

4.11

mmol/l

0.80

275

2195

(3035285) Chloride [Moles/volume] in Venous blood

281

2212

0.88

1.37

2.6

2.5

106.51

105.54

mmol/l

2.20

275

2194

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1265

8248

1.07

1.36

3.5

4.3

45.13

45.48

0.20

1246

8134

(3021788) Differential panel - Synovial fluid

334

2599

0.89

1.36

1.5

—

1.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

278

2188

0.88

1.35

2.6

1.20

mmol/l

0.06

272

2171

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1769

11653

1.06

1.34

3.1

4.1

1.23

mmol/l

1.69

1438

9972

(3000570) Elastase.pancreatic [Mass/mass] in Stool

541

4098

0.91

1.33

1.3

1.4

267.04

255.66

ug/g

0.66

306

2563

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

127

723

1.22

1.33

2.3

2.1

1.94

2.59

u/field

0.64

467

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

124

0.50

1.31

7.1

5.5

41.33

50.21

ug/min

—

107

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

232

1844

0.87

1.31

1.3

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3164

22648

0.96

1.29

2.2

2.7

20.08

20.80

2.40

2799

20814

(3003327) Ova and parasites identified in Stool by Light microscopy

389

2988

0.90

1.28

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.41

1.27

1.2

1.4

—

1.22

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

143

0.53

1.27

1.3

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

369

0.71

1.27

1.1

1.2

1.44

1.46

mmol/l

0.05

231

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

396

3036

0.90

1.26

1.6

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

236

0.64

1.23

1.2

1.4

87.28

73.48

1.38

201

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

193

0.61

1.22

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.60

1.21

1.1

1.0

—

(3020891) Body temperature

1095

7138

1.07

1.21

3.7

4.3

36.93

36.90

°c

1.44

1081

7062

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

235

0.65

1.21

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

1152

7523

1.06

1.21

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.47

1.19

1.2

1.1

—

9.14

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

430

3272

0.91

1.19

2.1

2.3

108.36

106.74

ug/min

0.02

231

1809

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.19

0.0

8.2

—

48.09

—

(3018291) Platelet Ab [Presence] in Serum

0.00

1.19

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.19

0.0

1.1

—

8.22

—

(3003740) Influenza virus B Ag [Presence] in Specimen

576

0.78

1.18

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

493

3725

0.91

1.18

1.1

370.00

160.24

titre

0.76

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

443

0.75

1.18

1.0

1.1

11.92

12.16

iu/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

241

0.66

1.17

1.2

1.1

68.71

81.28

—

127

(4198724) Urine methamphetamine measurement

1.64

1.16

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

113

1.53

1.16

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

758

0.81

1.15

1.1

3.44

4.84

eliau/ml

0.39

147

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

147

0.56

1.15

1.4

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.60

1.15

1.1

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

894

6591

0.94

1.15

2.0

2.4

2.96

g/l

0.03

744

5823

(3051101) Glucose [Moles/volume] in Cord blood

297

0.70

1.14

4.6

5.8

10.28

8.36

mmol/l

3.15

297

(3025018) Bordetella pertussis Ab [Titer] in Serum

393

0.74

1.14

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

568

3625

1.09

1.14

1.8

2.6

56.59

58.83

1.49

527

3466

(3016879) Cocaine [Presence] in Urine

272

1.32

1.12

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

650

4834

0.93

1.08

1.9

2.4

0.00

g/l

0.10

549

4189

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

510

3827

0.92

1.07

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

667

0.81

1.07

1.4

44.05

35.61

iu/l

1.06

558

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

169

0.61

1.07

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

260

0.69

1.06

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

574

0.79

1.06

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

340

0.73

1.06

1.2

1.3

2.63

765.18

u/l

—

124

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

426

0.76

1.05

1.9

360.61

344.77

mu/l

0.10

325

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

844

6208

0.94

1.04

1.9

2.3

10.43

10.21

g/l

0.62

682

5363

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

242

0.69

1.03

1.6

1.7

10.39

10.02

ug/l

0.16

242

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

270

1.31

1.03

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

283

1.30

1.01

1.4

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

677

0.82

1.01

1.1

4.97

9.30

nmol/l

0.46

147

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

363

1.26

1.00

1.1

1.05

1.16

u/l

1.23

168

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

676

5002

0.93

1.00

1.9

2.4

0.02

0.05

g/l

1.66

579

4444

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

962

6294

1.06

0.99

2.3

2.5

31.29

24.23

au/ml

0.72

419

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

199

0.66

0.99

5.1

7.0

11.11

10.12

0.64

199

(3011288) Drugs identified in Urine by Screen method Nominal

194

1.36

0.98

1.8

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

239

0.69

0.98

1.1

1.3

74.88

78.58

—

129

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.97

0.0

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

247

0.70

0.97

1.0

1.1

93.60

91.99

0.12

173

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

603

0.81

0.94

1.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

426

3198

0.92

0.94

3.4

4.4

8.08

8.34

kpa

2.05

409

3112

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

731

0.83

0.94

2.5

2.2

28.64

140.98

ug/min

2.50

169

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

293

1.28

0.93

1.1

—

(3019174) dRVVT (LA screen)

0.49

0.91

1.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.48

0.91

1.0

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

291

0.74

0.91

1.4

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

630

0.82

0.91

1.3

4.23

3.21

mmol/l

1.22

580

(3027008) Opiates [Presence] in Urine

289

1.27

0.89

1.4

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

507

0.80

0.89

1.2

1.3

39.95

40.37

g/l

0.11

239

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

114

920

0.86

0.88

1.1

1.2

103.86

101.19

pmol/l

0.22

114

920

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

333

1.25

0.88

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

290

1.27

0.87

1.4

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

229

1.30

0.87

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

596

0.82

0.86

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

296

0.75

0.86

1.3

1.16

1.18

mmol/l

0.74

296

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14127

97059

1.03

0.85

7.1

7.9

41.30

40.75

mmol/mol

8.48

12689

88104

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

550

4068

0.93

0.85

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3232

21806

1.03

0.83

1.7

1.9

29.48

30.03

5.57

3117

21198

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

159

1246

0.88

0.83

1.3

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

551

1.18

0.82

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.81

0.0

3.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.81

0.0

1.5

—

57.12

—

(36303858) Crystals [Presence] in Urine

0.00

0.81

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

621

0.84

0.81

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

427

3179

0.93

0.80

3.4

4.3

4.98

5.00

kpa

0.25

411

3093

(3006462) Nitrate [Presence] in Urine

613

0.83

0.80

4.3

4.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

509

3764

0.93

0.80

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

208

1.30

0.79

1.1

1.3

103.85

97.88

ug/l

0.09

133

(3012501) Base excess in Blood by calculation

427

3177

0.93

0.79

3.4

4.3

2.50

2.75

mmol/l

0.99

287

2210

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

268

0.75

0.79

1.1

1.2

37.17

306.09

u/l

0.86

184

(3027944) Amphetamines [Presence] in Urine

276

1.25

0.78

1.5

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

407

0.80

0.78

1.8

2.0

—

(40762814) Titanium [Mass/volume] in Blood

291

0.76

0.78

2.3

2.85

3.37

ug/l

0.89

117

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.78

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

656

0.84

0.78

1.9

1.8

93.16

99.01

umol/l

0.50

656

(3045683) HLA typing for celiac disease panel - Blood or Tissue

314

0.77

0.78

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

187

1158

1.12

0.77

1.3

548.18

417.80

titre

0.22

109

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1726

11541

1.04

0.77

2.2

2.5

52.31

48.66

u/l

0.09

1420

9655

(3022493) Free Hemoglobin [Mass/volume] in Plasma

595

0.84

0.77

1.1

2.6

56.26

70.96

mg/l

1.40

395

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

195

0.71

0.76

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.52

0.76

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

271

2050

0.91

0.76

2.2

28.95

26.66

mg/l

0.30

708

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

315

1.23

0.76

1.3

26.31

33.97

0.94

200

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9639

65991

1.02

0.75

4.3

6.6

12.48

12.49

umol/l

0.03

9000

62843

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

182

1128

1.12

0.75

1.3

47.00

66.02

titre

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

248

1.26

0.73

1.3

1.2

1.36

41.06

mg/l

0.79

184

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1813

12948

0.97

0.72

1.7

2.1

0.20

0.19

g/l

0.49

1604

11934

(3020491) Glucose [Moles/volume] in Blood

136

830

1.13

0.72

1.9

2.2

7.45

7.24

mmol/l

0.36

105

555

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

709

0.86

0.71

1.1

1.2

9.52

9.77

mmol/l

0.22

664

(3000034) Microalbumin [Mass/volume] in Urine

147

1141

0.89

0.69

2.7

3.1

32.67

39.67

mg/l

0.31

103

851

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

159

0.70

0.69

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.59

0.69

2.3

3.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

351

2612

0.93

0.69

1.6

1.7

22.00

12.07

iu/l

0.21

123

862

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1387

9941

0.96

0.68

5.3

7.9

1.39

1.28

4.90

1381

9865

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

198

0.73

0.68

1.1

1.2

19.08

17.88

u/l

0.12

132

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

133

0.68

0.66

1.2

3.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

836

6051

0.95

0.66

2.0

2.5

1.31

1.04

g/l

0.85

665

5058

(3002619) Bacteria identified in Specimen by Culture

321

1.21

0.66

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

296

1.22

0.65

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

379

0.82

0.62

1.6

113.39

114.82

ug/l

0.03

321

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1345

9623

0.96

0.62

5.4

8.2

0.68

0.62

6.08

1336

9556

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

2.56

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

446

0.84

0.61

1.3

1.4

16.98

21.01

0.62

371

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

187

1419

0.91

0.61

2.7

2.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

262.68

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.10

—

(3009015) Lactate [Moles/volume] in Synovial fluid

170

0.73

0.60

1.2

5.73

7.03

mmol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

293

0.80

0.59

1.1

1.2

0.71

1.49

mmol/l

1.05

186

(3032057) Clostridioides difficile [Presence] in Stool

351

1.18

0.59

1.5

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

643

0.87

0.58

1.8

1.9

38.54

39.52

g/l

0.90

643

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.57

7.0

8.3

—

(3000991) Gas panel - Venous blood

1834

13030

0.97

0.57

4.6

7.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.64

0.56

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

233

1491

1.08

0.55

3.5

3.6

11.32

12.41

index

1.15

112

783

(40762887) Creatinine [Moles/volume] in Blood

109

1.33

0.55

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.52

0.55

1.7

1.6

521.00

331.48

nmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

103

0.67

0.54

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

622

4504

0.95

0.54

1.9

2.5

0.00

g/l

-0.00

547

4179

(44786800) Granulocytes/Leukocytes in Body fluid

251

0.80

0.54

1.3

14.42

22.60

0.85

197

(3023520) Reticulocytes [#/volume] in Blood

2311

15638

1.03

0.53

2.0

2.5

64.41

67.63

e9/l

4.62

1700

11649

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1254

8414

1.03

0.52

5.8

8.6

15.82

15.72

0.65

1205

8126

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

324

1.18

0.52

2.4

2.5

7.12

7.77

mmol/l

0.92

218

(3036071) Salmonella sp Ab [Titer] in Serum

188

0.77

0.51

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

177

1332

0.92

0.51

1.3

1.4

149643.92

183927.97

e6/l

0.22

111

886

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

125

0.72

0.50

1.8

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

583

0.88

0.50

1.2

167.32

303.45

u/l

1.76

534

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3590

25236

0.98

0.48

3.3

3.7

0.86

ug/l

0.07

2635

18882

(4211845) Urine protein measurement

661

0.89

0.47

4.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.67

0.47

1.0

1.1

15.01

30.96

iu/ml

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

162

0.77

0.47

1.4

1.2

87.00

73.88

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.59

0.46

1.0

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

667

0.89

0.46

1.8

2.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

154

0.76

0.46

1.8

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

175

1.23

0.46

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.70

0.46

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

460

3336

0.95

0.45

2.4

2.8

16.17

15.75

2.46

448

3266

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

237

0.82

0.45

1.6

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1126

7570

1.03

0.44

3.0

3.6

25.36

25.13

mmol/l

1.41

1081

7357

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

150

955

1.09

0.44

1.7

104.70

110.52

ng/l

0.37

150

955

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.65

0.44

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

221

0.81

0.43

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.65

0.43

1.7

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.57

0.42

1.4

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.57

0.42

1.4

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

4417

30949

0.98

0.42

3.6

4.3

80.93

82.37

3.32

4306

30325

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

0.01

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

295

0.84

0.42

1.1

1.80

12.07

u/ml

—

(3044927) Protein electrophoresis panel - Urine

246

1810

0.94

0.42

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.42

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

430

1.13

0.41

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.2

—

2.37

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.5

—

389.85

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

249

0.83

0.41

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

411

1.13

0.40

1.1

—

(3001729) Color of Synovial fluid

122

1.25

0.39

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

472

1.11

0.38

1.7

1.9

12.69

14.04

nmol/l

1.10

428

(3013166) Neutrophils/Leukocytes in Synovial fluid

400

1.12

0.38

1.4

69.53

62.12

1.08

344

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.70

0.38

1.4

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.38

0.38

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

118

0.76

0.37

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

142

1.22

0.37

4.5

5.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

467

0.89

0.37

3.8

6.6

24.44

24.95

mmol/l

0.53

420

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7251

50564

0.99

0.36

3.1

3.5

2080.51

1936.71

ng/l

1.53

6248

44708

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

851

5727

1.03

0.35

1.2

1.3

54.43

59.85

au/ml

0.29

366

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

346

0.88

0.33

1.1

1.2

104.21

135.44

nmol/l

0.95

243

(44790048) Parainfluenza type 2 nucleic acid detection

213

1557

0.95

0.33

1.4

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

213

1557

0.95

0.33

1.4

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

213

1557

0.95

0.33

1.4

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

213

1556

0.95

0.32

1.4

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

132

1.21

0.32

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

345

0.88

0.32

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

145

1.19

0.32

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

160

0.82

0.31

1.2

93.60

70.14

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

174

0.83

0.30

1.1

1.4

13.52

16.02

mm/h

0.44

174

(3005011) Chlamydia sp Ab [Titer] in Serum

1.24

0.30

1.9

1.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.24

0.30

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.24

0.30

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.24

0.30

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

137

1011

0.94

0.30

1.9

2.1

3.02

4.11

ug/l

1.33

126

932

(37021550) Renin [Units/volume] in Plasma --upright

240

0.86

0.29

1.2

37.32

78.99

mu/l

1.83

174

(40757494) Bilirubin.total [Moles/volume] in Blood

107

688

1.08

0.29

1.8

2.1

17.38

27.60

umol/l

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3746

25651

1.01

0.29

2.2

2.7

10.99

11.57

umol/l

5.89

3315

23569

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

158

0.83

0.29

1.0

1.2

219.87

725.98

ng/l

0.46

103

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.32

0.28

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.33

0.28

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

180

0.85

0.28

2.4

0.68

0.66

ug/l

0.09

180

(3028271) Lactate [Moles/volume] in Capillary blood

359

2393

1.04

0.28

1.8

1.9

1.76

1.70

mmol/l

0.59

352

2321

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.76

0.28

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.23

0.27

1.0

—

12.67

—

(3052851) Hemolysis interference index of Serum or Plasma

598

4025

1.03

0.27

3.6

3.7

1.88

1.86

index

0.02

296

2071

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.67

0.26

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

674

4782

0.97

0.26

1.1

0.99

1.37

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

162

1.15

0.25

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.20

0.25

1.0

—

(3020650) Glucose [Presence] in Urine

316

0.90

0.25

3.0

1.6

0.00

0.04

estimate

1.34

316

(3017704) Immunofixation for Urine

142

930

1.06

0.24

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

156

1.15

0.24

2.6

3.1

44.11

38.87

umol/l

0.48

127

(3000060) B lymphocytes [#/volume] in Blood

162

0.85

0.24

2.0

1.7

0.06

1.66

e9/l

1.76

(3025577) Chromium [Mass/volume] in Blood

133

972

0.95

0.23

2.0

2.1

1.73

2.35

ug/l

2.73

110

804

(3000475) Leukocytes [#/volume] in Synovial fluid

487

3463

0.97

0.23

1.6

19191.14

14761.09

e6/l

0.86

339

2401

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

242

0.89

0.23

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

105

1.19

0.23

1.2

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

328

0.91

0.22

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

2182

14924

1.01

0.22

1.7

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

991

6980

0.98

0.22

1.8

1.9

2.36

2.19

ug/l

0.13

779

6095

(3018851) Theophylline [Moles/volume] in Serum or Plasma

168

0.86

0.22

1.5

1.7

42.38

48.91

umol/l

0.60

168

(3046861) Legionella sp Ag [Presence] in Urine

0.81

0.22

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.24

0.22

1.7

1.9

17.43

17.99

umol/l

0.05

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

262.57

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.22

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.6

—

301.43

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

2.09

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.22

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

0.22

0.0

1.8

—

9.00

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.8

—

8.88

—

(3034614) HLA Ag [Interpretation]

0.00

0.22

0.0

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

226

0.89

0.21

1.1

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(4133840) Spirometry

167

0.87

0.21

1.6

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.26

0.20

1.2

1.0

123.80

177.65

pmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.79

0.20

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

118

857

0.95

0.18

1.6

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

548

1.06

0.18

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

302

0.92

0.18

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

352

0.92

0.18

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.72

0.17

1.8

1.5

—

(3000330) Specific gravity of Urine by Test strip

1105

7545

1.01

0.17

3.9

4.2

1.02

ratio

1.84

975

6868

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

171

0.89

0.16

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.13

0.16

1.1

203.87

297.35

nmol/l

—

(3024869) Neuronal Ab [Presence] in Serum

257

0.92

0.16

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.78

0.16

1.0

1.1

502.00

322.09

u/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.83

0.16

4.2

4.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.19

0.15

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

116

1.13

0.15

1.1

1.71

1.68

umol/24h

0.07

116

(3045414) Leukocytes [Presence] in Urine

1813

12649

0.99

0.13

2.2

0.00

0.01

estimate

2.03

244

2170

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.86

0.13

1.1

10.17

11.24

u/l

0.14

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

447

1.05

0.13

7.4

5.7

59.27

72.77

2.59

341

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

168

0.91

0.13

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

265

1.07

0.13

1.2

1.1

0.64

0.66

umol/24h

0.05

114

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1998

13925

0.99

0.12

2.1

2.6

8.59

10.30

umol/l

3.12

1700

12230

(3025549) Creatine [Moles/time] in 24 hour Urine

124

0.89

0.12

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

102

0.88

0.11

1.1

1.5

1.05

1.27

mmol/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3481

24201

0.99

0.11

2.2

2.7

2.19

2.24

g/l

5.91

3085

22097

(3035320) C reactive protein [Mass/volume] in Body fluid

133

948

0.97

0.11

3.5

2.9

30.57

31.57

mg/l

0.11

103

715

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

1.09

0.10

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

101

0.89

0.10

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

370

0.95

0.09

1.5

1.6

0.38

ug/l

0.04

230

(3034274) Bile acid [Moles/volume] in Serum --fasting

454

0.96

0.09

1.3

6.29

15.59

umol/l

3.16

315

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.82

0.08

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.77

0.08

1.6

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

209

1.06

0.08

1.1

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.13

0.07

1.0

5.00

5.15

mmol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.04

0.07

1.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

545

3805

0.99

0.07

1.4

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

268

0.96

0.06

1.1

235.96

278.77

pmol/l

0.60

187

(3014891) Appearance of Pleural fluid

299

1.04

0.06

1.4

1.6

—

(3049717) Cytology report of Urine Cyto stain

955

6650

0.99

0.06

2.8

2.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.86

0.06

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

148

1041

0.98

0.05

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.10

0.05

1.1

6.20

6.19

mmol/l

0.02

(3026389) Candida sp identified in Specimen by Organism specific culture

235

1641

0.99

0.04

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

856

5947

1.00

0.03

2.7

3.3

4.27

4.30

pmol/l

0.39

731

5144

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

296

1.03

0.03

1.2

1.1

1504.80

1670.79

miu/ml

0.48

296

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1496

10322

1.00

0.03

1.8

2.3

403.79

391.84

nmol/l

1.34

1306

9418

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

109

744

1.01

0.03

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

109

744

1.01

0.03

1.2

1.4

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

173

0.96

0.03

3.1

2.8

1.88

2.13

0.22

168

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

1.05

0.03

1.1

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.92

0.03

1.6

1.3

1.20

1.00

u/field

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

147

1027

0.99

0.02

2.1

2.0

288.07

308.69

mu/l

0.31

136

945

(3032773) Endomysium IgG Ab [Titer] in Serum

113

789

0.99

0.01

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

155

1066

1.01

0.01

1.2

1.16

1.49

nmol/l

5.43

138

961

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

635

0.99

0.01

1.4

14.64

15.17

umol/l

0.22

586

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

0.96

0.00

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

0.95

0.00

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.03

0.00

1.1

112.00

107.46

titre

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

1.01

0.00

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

342

0.99

0.00

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

388

1.00

0.00

1.1

1.2

10.88

14.13

pmol/l

0.26

148

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.05

0.00

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.00

0.00

1.0

1.1

0.86

1.04

u/field

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

363

0.99

0.00

2.1

2.0

13.62

45.98

u/l

3.74

345

(4212803) Bone marrow aspirate examination

152

1.00

0.00

1.2

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

290

1.00

0.00

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

341

0.99

0.00

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

765

5294

1.00

0.00

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.00

0.00

1.9

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2068

14309

1.00

0.00

4.4

4.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

23.67

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.5

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.75

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

22.90

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.99

0.00

1.4

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.95

-0.00

1.0

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(1616488) Thyroxine (T4) free [Moles/volume] in Cord blood

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.01

-0.00

1.0

—

35.67

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.97

-0.00

1.2

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.99

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_ALZHEIMER_INCLAVO – Alzheimer disease, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer disease, including avohilmo (G6_ALZHEIMER_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints